Fenway Health advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. We center LGBTQIA+ people, BIPOC individuals, and other underserved communities to enable our local, national, and global neighbors to flourish.. Learn more by clicking on the sections above.
To Our Community Members,
Over the past year, Fenway Health marked its 50th anniversary in two ways that we expect will be remembered and remarked upon 50 years from now.
First, we applied five decades’ worth of knowledge and expertise gained in the provision of healthcare, study of science, and advocacy for health equity to the global fight against COVID-19:
Second, we laid the foundation for success over our next 50 years by approving an ambitious strategic plan that centers racial equity and social justice in Fenway’s operations, care, and services; advances health equity among those Fenway serves; and pushes to dismantle and redesign systems that deprive BIPOC and other underserved people of the opportunity to be healthy and thrive.
Through it all, our staff has continued to meet the needs of the people who count on us, and to deliver on our mission. By expanding our telehealth program to ensure continuity of care during the COVID-19 public health emergency, we were able to care for more than 34,000 patients in 38 states, and earned recognition from the U.S. Health Resources & Service Administration for being one of just 36 community health centers in the country that exceed national clinical quality benchmarks for chronic disease management and preventive care.
The year was enormously challenging, to be sure, and it called upon us to dig deep. But we were made for times like these. Our experience has affirmed that Fenway Health is just as nimble, resilient, creative, and innovative today as we were 50 years ago—and will be 50 years from now. When committed, resourceful people of good will come together in service to a common vision, anything is possible.
Thank you for being part of the Fenway Health community.
Centering racial equity is critical to the mission of Fenway Health. We were founded to serve under-resourced and marginalized communities, and advocacy is a core component of our mission. We know that we need to do more to center racial equity and social justice in everything we do and to work to undo disparities and inequities that exist in the services we provide, the people we reach, and the outcomes we achieve.
We have committed to taking the necessary actions that will ensure that our entire organization is engaged in racial equity and social justice service delivery and practice. Everyone within our organization will be involved in this work – our Board of Directors, organizational leadership, staff, and volunteers – and we are focused on how we engage our patients, clients, and community partners as well.
As part of these efforts, we unveiled a new mission statement, Strategic Plan, and Racial Equity Action Plan at our virtual Spring Board of Visitors Meeting and Fenway@50 Annual Meeting. They were the culmination of a year-long effort evaluating our work and focusing the lens of racial justice on all of our upcoming initiatives.
At our 2021 Annual Meeting, Fenway Health unveiled our new mission statement, 5-year Strategic Plan, and Racial Equity Action Plan, all designed to make us a more just and equitable organization.
Fenway Health advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. We center LGBTQIA+ people, BIPOC individuals, and other underserved communities to enable our local, national, and global neighbors to flourish.
Adoption of 2021-2025 Strategic Plan
The Fenway Health 2021-2025 Strategic Plan was developed during 2020–2021 to cover the operating period of July 1, 2021 through June 30, 2026. The Strategic Plan was approved for adoption by the Fenway Health Board of Directors via a vote at the June 8, 2021 Board of Directors meeting, and recorded in the meeting minutes. As Chair of the Fenway Health Board of Directors, my signature affirms the Board of Directors’ approval for adoption of the 2021-2025 Strategic Plan:
Jonathan I. Matsui, PhD
Chair, Fenway Health Board of Directors
We are committed to becoming an antiracist organization. We know that we are only at the beginning of this journey. Our work will be ongoing, multidimensional, incremental, and ultimately transformative.
Over time, we will begin to look and act different: Leadership will change; How we design, implement, and evaluate our care models, research, advocacy, and services will change; The people who come to count on us, who want to work with us, who support us will change; and ultimately, Lives will change.
Fenway Health’s Racial Equity Action plan lays out ambitious but achievable goals for the first 12 months; the next 18-30 months; and then 36-60 months. When we announced our commitment to becoming an anti-racist organization, we promised to be transparent and provide regular updates on our work and accomplishments along the way. One of the ways we will do that is on our , which we encourage everyone to visit. We’ll also be talking about this work on our blog and in messages to our staff, patients, and community from our CEO, Board Chair, and others as we continue this work.
From Words To Action: Mapping The Fenway Health Racial Equity And Social Justice Journey August 3, 2020
From Words To Action: An Update November 23, 2020
Fenway Health Announces Five-Year Strategic Plan Anchored by Racial Equity Action Plan June 10, 2021
From Words To Action: Acknowledging Fenway Health’s Past And Moving Forward With Intention And A Plan June 16, 2021
Thomas Martorelli, former Fenway Board Chair and author of For People, Not For Profit, a history of Fenway Health.
In 2021, Fenway Health celebrated 50 years of caring for our community. Founded in 1971 in the basement of a Massachusetts Avenue building owned by the Christian Science Church, Fenway now operates three clinical sites, three public health locations, and a resale thrift store chain that helps support our operations.
Originally started as a one day a week drop-in center operated by volunteer medical students, we now offer medical, behavioral health, dental and eye care, two pharmacy locations, and a number of specialized services including our Violence Recovery Program, Transgender Health, HIV and STI testing and prevention, LGBTQIA+ parenting and alternative insemination services, radiology, and COVID-19 testing, vaccinations, and care. The Fenway Institute operates biomedical, behavioral health, population level research studies, public policy and advocacy programs, and a training and education division. You can learn more about our history here.
To help commemorate our 50th birthday year, Fenway held a free virtual gala celebration on April 28, 2021. The event featured Dr. Anthony Fauci as our keynote speaker and to look back at our successes and forward to the future. The night was a resounding success, with hundreds of attendees and a silent auction and fundraising challenge that raised more than $345,000 to support care and services at Fenway Health.
Weren’t able to attend? No worries! You can watch the whole thing, including Dr. Fauci’s speech, here. (Note: Program begins around the 42 minute mark).
Fenway’s Pride in Your Health podcast series posted several interviews commemorating our 50th year.
Pride in Our Health explores a different LGBTQIA+ health topic each episode, taking a deep dive into a wide range of important topics across health and wellness. We’ll discuss the latest care options, learn about lifesaving medical breakthroughs, and gather expert advice on how to be a happier, healthier you. You can subscribe to Pride in Our Health on iTunes, Apple Podcast, Google Play, or Spotify.
On June 10, 2021, Fenway Health held our virtual Spring Board of Visitors Meeting and Fenway@50 Annual Meeting. We unveiled a new mission statement, Strategic Plan, and Racial Equity Action Plan at both of them with the goal of centering equity and social justice in everything we do. They were the culmination of a year-long effort evaluating our work and focusing the lens of racial justice on all of our upcoming initiatives.
At our 2021 Annual Meeting, Fenway Health unveiled our new mission statement, 5-year Strategic Plan, and Racial Equity Action Plan, all designed to make us a more just and equitable organization.
Fenway Health advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. We center LGBTQIA+ people, BIPOC individuals, and other underserved communities to enable our local, national, and global neighbors to flourish.
From Words To Action: Mapping The Fenway Health Racial Equity And Social Justice Journey August 3, 2020
From Words To Action: An Update November 23, 2020
Fenway Health Announces Five-Year Strategic Plan Anchored by Racial Equity Action Plan June 10, 2021
From Words To Action: Acknowledging Fenway Health’s Past And Moving Forward With Intention And A Plan June 16, 2021
In every department, our staff is dedicated to meeting the needs of everyone who walks through our doors through integrated personal and compassionate care, regardless of their ability to pay. We offer a wide range of ever-growing services for the entire family within our clinical divisions, including medical, behavioral health, dental, vision, HIV/STI screening, pharmacy, women’s health, transgender health, alternative insemination and obstetrics, and the Violence Recovery Program. Our care and services are available at three Boston locations.
Fenway Health is affiliated with Beth Israel Deaconess Medical Center and all physicians hold faculty appointments at Harvard Medical School.We areaccredited by the Joint Commission on Accreditation of Healthcare Organizations.
In March 2020, Fenway welcomed Ellen LaPointe as our new CEO just as the COVID-19 pandemic rolled across the globe. Fenway Health pivoted to respond, moving the majority of our medical and behavioral health appointments to telehealth, standing up testing programs in Boston and Everett, and activating several COVID-19 research studies.
Patients
who made more than
Patient Visits
30,510 patients
105,031 visits
4,587 patients
46,421 visits
3,886 patients
15,451 visits
1,662 patients
2,295 visits
The Ansin Building, a 10-story, 100,000 square foot health care and research facility. It is the largest building ever constructed by an organization with a specific mission to serve the LGBTQIA+ community.
Fenway: South End, a private practice setting for medical and behavioral health care, women’s health, and pharmacy services conveniently located for those who live and work in Boston’s South End and Back Bay neighborhoods.
The Sidney Borum, Jr. Health Center, quality health care for young people ages 12 to 29—many of whom are LGBTQIA+, HIV-positive, living on the streets, using drugs or alcohol, engaging in sex work or gang involved—who may not feel comfortable going anywhere else.
Fenway has helped pioneer a philosophy of integrated care that looks at each patient as a whole person and our staff works as a team to meet the needs of everyone who comes through our doors.
Patient-Centered Medical Care
Fenway Health’s Ansin Building and South End locations are both certified as National Committee for Quality Assurance Level 3 Patient-Centered Medical Homes (PCMH). The PCMH model of primary care emphasizes care coordination and communication to transform primary care into “what patients want it to be.” In 2016, the Massachusetts Health Policy Commission named Fenway: South End the first practice in the state to achieve Patient-Centered Medical Home PRIME Certification for integrating behavioral health in primary medical care. Fenway’s Ansin Building Practice followed quickly, attaining PRIME Certification in early 2017.
Family Medicine
Fenway Health’s Family Medicine Program has expanded to all of our locations, allowing us to provide services to patients of every age group, from the youngest to the oldest.
Transgender Health
More than 5,100 transgender patients currently receive care at Fenway Health locations, an increase of roughly 4,000 patients since 2007. The Transgender Health Program continues to expand to comprehensively address the needs of our rapidly growing transgender and gender non-conforming patient base.
Women’s Health
Fenway’s Women’s Health Program seeks to meet the healthcare needs of all individuals who identify as women and/or have natal female anatomy, including lesbians, bisexual and transgender women; people who identify as gender non-binary; and people on the transmasculine spectrum. Our obstetrical services care program partners with Beth Israel Lahey Health to provide prenatal care for patients in all stages of pregnancy. The program also offers comprehensive birth control and emergency contraception services.
HIV Testing and Care
Fenway Health has been a community resource and safe space since the early days of the AIDS epidemic. Our health center saw the first HIV/AIDS cases in New England and, in 1985, was awarded the first HIV counseling and testing contract by the Massachusetts Department of Public Health. Today, Fenway remains one of the largest confidential HIV counseling and testing sites in the state and is New England’s largest provider of outpatient HIV/AIDS care.
Insurance Enrollment
1,286 patients visited our Financial Assistance department. Under Fenway’s health insurance enrollment program, patients without insurance can be enrolled in coverage under MassHealth, Commonwealth Care and Health Safety Net.
Fenway Pharmacy
Approximately $1.4 million in free and discounted medication was given to patients in need by the Fenway pharmacy’s two branches. The pharmacies also offer a free home delivery service for homebound patients and others unable to prick up their medication. Together, the two locations fill well over 500 prescriptions per day.
Alternative Insemination
Over 770 babies have been conceived through Fenway’s Alternative Insemination (AI) Program since its start in 1983, believed to be the first of its kind in the United States. In fiscal year 2021, the AI program saw 28 new pregnancies. In addition to insemination, the AI Program offers social and emotional support for LGBTQIA+ parents and prospective parents through a variety of workshops and groups.
Addiction Recovery and Wellness
3,049 patients were brought into care through Fenway’s Addiction Recovery and Wellness Program, which treats those struggling with substances like alcohol, cocaine and crystal methamphetamine. In 2017, the program added Problem Gambling Services. We never turn anyone away for lack of ability to pay, and many patients in the Program are referred into other services at Fenway.
Violence Recovery Program
332 survivors of domestic violence, sexual assault, hate violence and police misconduct were helped by the Violence Recovery Program (VRP) at Fenway Health. The VRP offers individual and group counseling to LGBTQIA+ survivors. VRP staff also conducts outreach and educational sessions to community groups and professional groups about LGBTQIA+ violence issues on a local, state and national level, including providing technical assistance and training to the Boston Police Department, District Attorney’s offices, hospitals, health centers, social service agencies and community and school groups.
Health Navigators
Fenway’s Health Navigators answered 2,652 calls, providing resources, support, and a friendly ear to people from all walks of life.
The National LGBTQIA+ Health Education Center provides educational programs, training, technical assistance, resources, and consultation to health care organizations with the goal of optimizing quality, cost-effective health care for lesbian, gay, bisexual, transgender, queer, intersex, asexual and all sexual and gender minority (LGBTQIA+) people. In FY2021, faculty from the Education Center presented at conferences and facilitated trainings and webinars, educating health care professionals on a range of topics from achieving health equity to care for transgender and gender-diverse patients, to care for LGBTQIA+ older adults, to affirming care for intersex patients. The Education Center also produced 13 new publications and resources in FY2021.
Archived Online Webinars
Interactive online learning modules on LGBTQIA+ health topics
Combined total view count in FY2020
People on email newsletter list
Advancing Excellence in Transgender Health
On October 16–19, 2020, The Division of Education and Training at The Fenway Institute hosted the 6th annual Advancing Excellence in Transgender Health Conference. This year’s conference was held virtually and saw a record number of 578 registrants from 46 US states, Puerto Rico, Belgium, Canada, Mexico, Pakistan, the Philippines, Portugal, and Singapore. This year the conference also included an optional half-day pre-conference for those seeking additional training on the basics of gender-affirming care before the start of the general conference. The conference agenda included a variety of sessions on important topics such as ‘creating an inclusive and affirming environment,’ ‘gender-affirming hormone therapy,’ ‘behavioral health care for transgender and gender-diverse youth and adolescents’ and ‘collecting gender identity data in EHRs.’ The conference also featured four community panels. Attendees were also able to network with each other and the speakers through Q&A sessions, virtual networking events and 1:1 private messaging in the conference platform.
In FY21 The LGBT Aging Project rebranded as the LGBTQIA+ Aging Project, consistent with Fenway Health’s expanded definition of the populations we serve. The LGBTQIA+ Aging Project focused much of its FY21 year work on response to COVID 19 and its impact on older alder adults. Staff and volunteers conducted nearly 600 outreach calls to LGBTQIA+ older adults in Massachusetts. The LGBTQIA+ Aging Project also convened a weekly Zoom Drop-In group to reduce social isolation and loneliness. The group met on Thanksgiving and Christmas to reduce isolation. In late 2020, the group expanded to meeting twice weekly, with a total registration of 75 participants. The LGBTQIA+ Aging Project convened monthly summits for a dozen organizations, providing training on virtual programming for LGBTQIA+ older adults so these organizations could improve their efforts to engage with and sustain relationships with LGBTQIA+ older adults. Throughout FY21, the LGBTQIA+ Aging Project conducted 40 trainings, workshops, and webinars for a total of 620 participants including three national and two local conferences. The LGBTQIA+ Aging Project also co-hosted the 10th annual LGBT Elders in an Ever-Changing World Conference, New England’s premier LGBT Aging Conference, for 256 participants (local, national, and international). The LGBTQIA+ Aging Project launched a Transgender and Gender Diverse Engagement Initiative reaching nearly 50 new people between the ages of 50-70. It hosted three bereavement groups for LGBTQIA+ people of all ages who have lost a loved one. In FY21, the LGBTQIA+ Aging Project also continued its leadership on the Massachusetts LGBT Aging Commission.
The Division of Education and Training partnered with many organizations to provide trainings on LGBTQIA+ health. Some of these partners include:
UCLA
Working with theDMH-UCLA Prevention Training Center of Excellence, the Division of Education and Training developed an online learning module that was distributed to staff across Los Angeles County. The course includes case scenarios that staff can use to practice responding to real situations they may encounter.
UPMC
The Division of Education and Training worked with University of Pittsburgh Medical Center (UPMC) to develop an application process for medical providers to obtain an LGBTQ+ Affirming Provider Designation in their member-facing provider directory including three educational modules. The modules were on “Introduction to Affirmative Care for LGBTQ+ Individuals,” “Health Care for Transgender and Gender Diverse Populations,” and “Sexual Orientation and Gender Identity Affirming Documentation and Systems.”
Children’s Omaha
In collaboration with Children’s Omaha, the Division of Education and Training developed an interactive learning module on “Achieving Equity for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ) People.”
During fiscal year 2021, The Fenway Institute’s Biomedical Research team continued to conduct clinical trials looking at new approaches to preventing HIV infection. As well as expanded to COVID-19 research on infection and transmission. Populations include both Adult and Adolescents. Our recruitment and outreach team has worked to represent Fenway at Pride Events in Massachusetts, World AIDS Day, organizations such as the Multicultural AIDS Coalition, Boston Lesbigay Urban Foundation, MA Commission on Youth, NAGLY, and BAGLY as well as at presentations at local colleges and universities throughout the year. As COVID-19 forced many events to move online, research staff adapted to move their events online and to represent Fenway at virtual events organized by other community organizations.
The Fenway Institute has operated one of the nation’s first federally funded community-based HIV research programs and has been a site for NIAID network research since 1993. As an active site for the HIV Prevention Trials Network (HPTN) and participating in protocols in the HIV Vaccine Trials Network (HVTN).
The Fenway Institute has participated in key HIV prevention efficacy trials that led to internationally significant breakthroughs, such as the iPrEX study, the first to demonstrate the efficacy of PrEP in preventing HIV infection. More recently, we participated in the DISCOVER trial that demonstrated a second oral medication is effective as PrEP and the recently completed HPTN 083, which demonstrated the efficacy of an injectable medication for PrEP for the first time ever. Since March 2020, The Institute has been deployed to work on COVID-19 research as part of the NIH Coronavirus Prevention Network (CoVPN).
Fenway completed the first CoVPN study in January 2021 and is now conducting clinical trials to understand COVID-19 transmission.
HVTN 117
HVTN 117 examines both tolerability and the immune system’s response to a new HIV vaccine. HIV Vaccine study in healthy adults, HIV uninfected, ages 18–50. No longer currently enrolling, in active follow up.
HPTN 089
In 2021, The study activities are complete and pending closure. The study explored 4 HIV antibodies in different combinations. The antibodies in HPTN089 are in the first phase of research; it is not an efficacy trial. Participants receive one infusion and participate in the study for 18 months.
HVTN 124
HVTN 124 examines both tolerability and the immune system’s response to a new HIV vaccine. This vaccine is made using laboratory products that look like HIV to generate an immune response. It is impossible for the vaccine to give someone HIV. Participation for this study includes 12 visits over the course of about 18 months.
HPTN 133
This phase I clinical trial to evaluates the safety and immunogenicity of an HIV-1 MPER peptide liposome vaccine in healthy, HIV-uninfected adult participants. Participants will attend several study visits through Month 12. All activity is completed and unblinding is pending.
HPTN 092
HPTN-092 tests the tolerability, safety, and the immune system’s response to combinations of experimental HIV antibodies. Participants are 18–50 years, HIV uninfected of all genders and sexualities. Actively enrollment is closed, we have one participant in follow up.
HPTN 083
Fenway was the only center in New England to enroll participants in HPTN 083, which evaluated injectable cabotegravir given every 8 weeks after 2 loading doses 4 weeks apart compared to daily oral tenofovir/emtricitabine to prevent HIV acquisition in MSM and transgender women. The initial study demonstrated the superiority of injectable cabotegravir, which led to FDA approval, and participants are now being followed to see if the prevention benefit is maintained over time.
HVTN 706
Currently we are enrolling for a Phase 3 HIV Vaccine study called MOSAICO testing for the safety and efficacy of an investigational vaccine. MOSAICO is the third HIV vaccine efficacy trial in progress worldwide. This trial will enroll 3,800 HIV-negative men and transgender people aged 18 to 60 years who have sex with men and/or transgender people. Clinical research sites are in the US, Argentina, Brazil, Italy, Mexico, Peru, Poland, and Spain. Enrollment has recently closed.
Project AMP
Project AMP studied whether a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV strains that were sensitive to the bnAb. This was assessed by a laboratory test that measures a virus’ susceptibility to neutralization by an antibody. Although overall, the use of the antibody did not protect against HIV in the primary analysis, a subset of patients with viral strains that were more susceptible to neutralization by the antibody achieved some protection from HIV infection. This finding is helping to inspire studies of combinations of antibodies that may provide better protection against HIV.
Observational
HVTN 405
The purpose of this study is to learn more about infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name “coronavirus.” It can cause the disease called COVID-19. The information gained from the study will be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines and treatments by allowing researchers to determine the difference between the body’s immune response to natural SARS-CoV-2 infection and immunization with a SARS-CoV-2 vaccine. Enrollment is closed and all study activities at our site have been completed.
Prevention
CoVPN 3002
The COVID-19 Vaccine study is testing how safe and effective the vaccine is in protecting against COVID-19. Participants may be eligible if they are 18 years or older and have tested negative for COVID-19. There are 10 or more visits over the span of 1-2 years. Enrollment closed, active follow up with over 200 participants.
CoVPN 3502
The COVID-19 Household study is testing how safe and effective the treatment is in protecting people against COVID-19 exposure. Participants may be eligible if they are 18 years or older and have tested negative for COVID-19. There are 12 visits over the span of 10 months. Enrollment closed, active follow up 7 people completed.
CoVPN 3006
PreventCOVIDU is a study across the US to learn whether the Moderna COVID-19 vaccine stops the spread of the SARS-CoV-2 virus: both getting infected — even without symptoms — and spreading it to others. Participants may be eligible if they are 18–29 years old and have tested negative for COVID-19. There are 5 visits over the span of 5 months. The study is actively enrolling.
MyChoices
The MyChoices study is an intervention investigating the feasibility and acceptability of MyChoices, a theory-driven mobile app to increase HIV testing and PrEP uptake by young men who have sex with men (YMSM), ages 15-24. The MyChoices app was refined in theater testing and an open technical pilot. The acceptability and feasibility of the updated app was evaluated in a pilot randomized controlled trial (RCT) among YMSM at risk for HIV acquisition in the US. Phase III (RCT) opened to accrual in October 2018 and participant follow-up completed in November 2019. The cohort was fully enrolled with 60 participants on April 2019.
LifeSteps for PrEP for Youth
The ATN’s LSPY protocol entails a two-phase study exploring PrEP adherence through a Cognitive Behavior Therapy based intervention. The first phase includes individual, qualitative interviews with approximately 20 YMSM and 10 key informants for intervention adaptation and refinement. The second phase is a pilot randomized controlled trial (RCT) of up to 54 YMSM to assess feasibility, acceptability and preliminary efficacy of the LSPY compared to standard of PrEP care only to improve PrEP adherence. Our long-term goal is to develop scalable protocols to optimize at risk YMSM’s PrEP uptake and adherence in order to decrease HIV incidence. The adaptation for LifeSteps for PrEP for YMSM will be informed, developed, and refined through formative research that involves YMSM at all levels. Phase 1 has been completed, and enrollment of the pilot RCT began in September 2019. Currently, at Fenway, the study has exceeded its target recruitment number but is still open to enrollment for young cisgender men who are recent and first-time users of PrEP.
P3
P3 is a three arm, randomized-controlled trial (RCT) that tested the efficacy of the P3 app. P3 is a novel, theory-based mobile app that utilizes game mechanics and social networking features to improve PrEP adherence, retention in PrEP clinical care and PrEP persistence among young men who have sex with men (YMSM) and trans women who have sex with men (YTW), ages 16-24. The study is testing the efficacy of P3 and P3+, which adds Next Step Counseling delivered by an adherence counselor through the app, against PrEP standard of care. Participants will be randomized to P3, P3+, or standard of care. A cost comparison between P3 and P3+ will be conducted. Enrollment for P3 began in May 2019 and recently closed in August 2021.
COMPARE
In years 1-3 of the iTech branch of the Adolescent Trials Network, we have optimized and pilot-tested, using a similar study design and identical study outcomes, two distinct mobile apps, LYNX and MyChoices. The apps are designed to increase HIV testing and PrEP uptake among YMSM. The apps were developed based on different theories of behavior change, and therefore contain different components, differing messaging strategies and different approaches for engaging youth. The individual apps will be tested simultaneously in this follow-on research study to evaluate for efficacy; participants will be randomized to receive LYNX, MyChoices, or Standard of Care. Comparing the apps will allow us to identify any efficacy differences in increasing HIV testing or increasing PrEP uptake between the two apps. If justified, we will combine the components of each app that have the greatest impact on behaviors into a final, composite app for dissemination. Enrollment for COMPARE began in September 2019 and is still currently enrolling, HIV uninfected, cisgender men who have sex with men between the ages of 16-29.
TechStep
TechStep is a three-condition, technology-based randomized controlled trial (RCT) focused on stemming HIV and sexual health risk in trans youth. The study utilizes aa stepped care approach where, if deemed necessary, some participants are stepped up to be randomized to receive counseling from an in-app eCoach to discuss issues of trans health and sexual health. The study focused on enrolling high-risk HIV-negative trans feminine, trans masculine, and gender non-conforming youth with the intent to reduce sexual risk behaviors (e.g., condomless anal intercourse, engagement in sex work, sex while feeling the effects of alcohol or drugs) and increasing PrEP uptake. Enrollment for TechStep began in September 2019 and ended in September 2021.
Injectable PrEP for Youth
In continuation of our decades-long commitment to treating and preventing HIV/AIDS, Fenway Health is a testing site for another study that explores whether injectable cabotegravir is an effective method for PrEP in youth (people under 18 years old.) The parent study of Injectable PrEP for adults was proven safe and effective. Just as safe, if not more than Truvada.
Youth ages 13-24 make up 21% of new HIV infections (CDC, 2017). Having the option of taking a pill every day or receiving an injection every 8 weeks allows the individual to make the right decision for themselves. We don’t want to leave youth behind in the development of new HIV prevention methods. Enrollment for Injectable PrEP for Youth started in April 2, 2020 and is still currently enrolling.
PrEP @ Home
The Fenway Institute continues to enroll for the PrEP @ Home Study, a trial of a home-based system of PrEP care that involves mail-in STI and HIV testing, as well as video conferences with a study provider. Since participants must be new to PrEP in order to be eligible, our research recruitment team has worked hard to develop new, creative outreach strategies to reach people not already engaged in PrEP care. Actively enrolling.
LifeSteps PrEP Adherence Study
Fenway Health, in conjunction with the University of Miami, is conducting research to investigate new ways to help adults stick to their daily PrEP regimen. Participants must be new to PrEP, 18 years or older, assigned male at birth and have sex with men. Actively enrolling.
Merck PrEP User Acceptability Study
The Merck PrEP User Acceptability study is two-phase project sponsored by Merck & Co, Inc. The purpose of this study is to understand how young men who have sex with men ages 18 to 34 feel about current and upcoming ways to take HIV PrEP. including implantable and less frequent dosing, and which ones they use and why. As new methods of preventing HIV are developed, we want to hear the thoughts YMSM have about them. In phase 1, through focus groups, we hope to learn their thoughts about a variety of long-acting PrEP agents, including monthly pills, injections, and implantable rods. Participants will also be asked to share their knowledge about oral PrEP, long-acting PrEP agents, PrEP stigma, PrEP costs, and whether long-acting agents might enhance retention in PrEP care and adherence to PrEP guidelines. In phase 2, we will conduct a multi-regional quantitative survey to assess the same questions within a larger popualtion. The User Acceptability study will begin enrolling Fall 2021.
Project Matter
Project Matter is a refined text-enhanced psycho-behavioral randomized control trial to reduce under-addressed and modifiable barriers to engagement in HIV care, including internalized stigma and related emotions, among HIV-positive men who have sex with men who use substances and are sub-optimally engaged in HIV care. The project is funded by NIDA and aims to elucidate behavioral and social mechanisms associated with substance use and optimize treatment success among this population.
PrEPsteps
PrEPsteps is a study funded by the National Institutes of Health to build and test a smartphone-based PrEP adherence system that responds to adherence data collected through a novel digital pill, with a focus on improving PrEP adherence among who have sex with men (MSM) who use stimulants.
DigiPrEP
DigiPrEP is a Gilead Sciences-funded study to test the use of a digital enabled PrEP (DigiPrEP) to measure PrEP adherence in men who have sex with men (MSM) who use substances other than alcohol.
The Algorithm Study
The Algorithm Study provides smoking cessation pharmacotherapy recommendations integrated into HIV primary care for people living with HIV who smoke cigarettes.
Project QUIT
Project QUIT is a behavioral intervention to treat anxiety and depression and to increase rates of smoking cessation among people living with HIV who smoke cigarettes.
National HIV Behavioral Surveillance (NHBS)
National HIV Behavioral Surveillance (NHBS) was conducted by Fenway Health in conjunction with the Massachusetts Department of Public Health and Centers for Disease Control and Prevention. The goal of NHBS is to help establish and maintain a surveillance system to monitor selected risk behaviors, HIV testing, prevention services, and HIV prevalence among groups at highest risk for HIV infection. NHBS completed 2021’s MSM cycle using a hybrid remote/in-person model, with a focus on Men who have Sex with Men in the Boston area.
MaxM
MaxM is a study that aims to learn from the experiences of young Black men who have sex with men. MaxM seeks to design a program specifically for this group to help protect their sexual health and wellbeing.
LEGACY Project
The LEGACY Project is a longitudinal cohort of Fenway transgender and gender diverse patients. In fiscal year 2021, The Fenway Institute had 5,811 patients whose electronic health record (EHR) data is included in the cohort. Of those patients, 1,377 completed an additional survey that helps fill in the gaps in EHR data. This allows the Epidemiology team to look at more extensive psychosocial factors and patient experiences with hormones, surgeries, and other gender-confirming treatment. LEGACY’s enrollment recently ended.
LITE Study
The LITE study is a longitudinal cohort of HIV-negative transgender women spanning the Eastern and Southern US. Enrollment closed at the end of August 2020; a total of 159 enrolled at Fenway. All participant study visits have continued to be done remotely. Participants are mailed at-home HIV and STI testing kits by Molecular Testing Labs and complete follow-up surveys either online, on the study app, or over the phone every three months. Participants are followed for a total of four years.
LITEPlus Study
The LITEPlus study is a longitudinal cohort of Black and/or Latina transgender women that looks at the effects of stress on cardiovascular health. Study enrollment is ongoing; a total of three individuals have enrolled at Fenway. For much of FY21, study enrollment was done remotely, but as of June 2021, in-person enrollment has resumed..
Life+Health
Life+ Health is a population-based study of patients at Fenway Health, Mattapan Community Health Center, and Harvard Street Neighborhood Health Center (in partnership with Harvard T.H Chan School of Public Health) that aims to advance methods to measure and analyze explicit and implicit discrimination in population health research. In FY21, 538 Fenway patients enrolled in the study (560 total).
Project IMPACT
Project IMPACT is a longitudinal cohort study to test a behavioral intervention created for men who have sex with men who use stimulants (meth, cocaine, crack) in the context of sex. In FY21, 19 participants were enrolled.
PrEP for Health
PrEP for Health is a randomized control trial study being carried out in the context of two community-based syringe service programs in Massachusetts (ACCESS Drug User Health Program and the Greater Lawrence Family Health Center) that uses a health navigator-based strategy and motivational interviewing to increase PrEP uptake and adherence among people who inject drugs, a population at high risk for HIV. The study began enrollment in September 2021 and, to date, participants are starting to complete their three-month assessment milestone in the study. Across both sites, 38 people have enrolled to date.
The Fenway Institute supports clinical, research and public health services through state-of-the-art health informatics and data systems. Fenway’s Informatics and Data Center continues to be a leader among Community Health Centers in developing data capacity and Health Information Technology (HIT) innovations.
We continue to refine our integration with Electronic Patient Reported Outcomes (ePRO) enabling us to develop algorithms to better meet the clinical needs of patients and quality measures. They provide consultation and technical assistance on federal initiatives and to federal agencies and CHC’s on HIT, data management activities that streamline and improve data capture and reporting processes. Our Data Center collaborates with other departments to provide clinical, financial and productivity data.
The Center quickly developed and implemented technologies in response to COVID-19. As a result, Fenway was able to rapidly pivot to Telehealth to reach some of the most vulnerable populations. We are currently using telehealth for clinical care, research and public health initiatives. We collaborated with a vendor to develop automating the reporting of COVID-19 negative results to patients using text messaging.
The Center worked closely with athenaHealth, our Electronic Health Records (EHR) vendor, to develop a product called ‘Centricity Now’ that will enable hospitalists and on-call providers to access to patient records wherever they are. We also work with other HIT vendors on initiatives using latest technologies to improve patient communication and health outcomes. For example, Fenway has collaborated on a project developing standards for using FHIR to transmit social determinants of health data. Additionally, we conduct webinars and in-person trainings around the US on SOGI implementation and analyzing outcomes.
The Data team has produced over 75 data analysis sets from our EHR focusing on LGBTQ patients and continues to advise other EHR vendors on refining their products to meet the needs of the LGBTQIA+ patients. It also collaborates with national and federal partners to develop tools to monitor health outcomes; for example, Fenway worked with NACHC and CDC to evaluate a Hepatitis C Care Cascade. The Center participates in many national data registry projects, whose funders include NIH and PCORI. These projects combine de-identified patient data into a shared clinical database to evaluate patient outcomes in real world settings.
C-NICS
The Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) research network integrates longitudinal clinical data and treatment management of persons living with HIV (PLWH) and provides research infrastructure to support HIV-associated clinical, social, behavioral outcomes, and comparative effectiveness research using data collected from 8 Centers for AIDS Research clinical sites across United States. CNICS has reviewed over 180 concept studies to date, resulting in over 350 peer reviewed manuscripts and over $125M in external funding awards to investigators working in CNICS.
Since 2001, more than 2,800 patients at Fenway Health have enrolled into C-NICS and over 15,000 individual blood specimens have been collected and processed for the biological specimen repository.
NA-ACCORD
An NIH-funded data registry that is a regional collaboration of single-site and multi-site cohorts that includes over 90,000 patients from more than 50 sites throughout the United States and multiple provinces in Canada. Comprised of both academic medical centers and community-based facilities that deliver HIV-primary and specialty care, this registry combines classical epidemiological and clinical HIV cohorts, includes both HIV-seropositive and seronegative persons, and is complemented by specimen repositories for conducting translational research.
PCORnet & ADVANCE
Of the 12 national networks that make up PCORNet, a patient-centered data registry that helps answer questions important to patients, Fenway Health contributes data quarterly to the ADVANCE network. ADVANCE is the nation’s largest safety-net community laboratory, consisting of researchers, patients and clinicians. ADVANCE’s is currently composed of 7,027,332 patients, 172 health systems, 31 states, and 1,607 clinic sites. Since the beginning of pandemic in 2020, Fenway has also been contributing weekly COVID-19 related data to ADVANCE.
EVERYWOMAN
EVERYWOMAN is examining the impact of the Affordable Care Act (ACA) and state level reproductive health policies on the full spectrum of women’s health care provision and health experiences in safety-net populations. EVERYWOMAN applies a mixed-methods approach comprising patient-level electronic health record (EHR) data for large scale quantitative analyses, qualitative observations, and semi-structured interviews with patients and providers to understand perceptions and patterns of care delivery and utilization, and review of state-level reproductive health policies in inform our analyses.
Findings from this study will identify practice and policy efforts to strengthen the provision of timely, effective, evidence-based reproductive health care. Study findings will impact patients and providers through relevant practice and policy changes to improve health outcomes and reduce disparities among low-income vulnerable populations of women.
PROSPER-HIV
The PROSPER-HIV study is examining the effect of physical activity and dietary intake as effective symptom management strategies for people living with HIV (PLWH), who experience a disproportionately high symptom burden (e.g., fatigue, insomnia, pain) with few treatment options. For this three-year NIH-funded study, 850 PLWH across three CNICS sites (115 at Fenway Health) will complete an annual series of physical activities and dietary recall interviews. Additionally, participants are asked to wear a fitness tracking device to monitor physical activity routines for a week.
Marijuana Policy Change:
This is a three-phase qualitative investigation examining the role that legalization and policy changes around marijuana possession and consumption impact attitudes and patterns of use of marijuana, alcohol, and tobacco products among people living with HIV (PLWH).
Four of the C-NICS-affiliated CFAR sites are seeking to enroll 90 participants, who will participate in interviews, focus groups, and questionnaires. The results collected from this study will seek to understand changing patterns and potential consequences of marijuana and other substance use, strengthen tailored substance use interventions, and inform future policy.
In this past year, staff at The Fenway Institute completed their target of 12 remote concept interviews. After the phase one data is analyzed, we will continue to enroll participants for the second and third phase of this study.
Transgender Patient Engagement in Biomedical Research
Transgender patient participation is greatly underrepresented in biomedical research. To better understand the barriers associated with study engagement, 15 Interviews with transgender patients who have and have not participated in biomedical research. Additionally, 15 interviews with clinical staff involved in providing care or recruiting transgender patients to biomedical research will also help to determine what gaps exist for the recruitment of this population, and whether additional training or other skills may be useful to assist with study recruitment of this patient population. Recruitment for this study will begin in September 2021.
PCORI-SOGI
This 3-year study involves 12 CHCs across the country that are part of, and extended from, the HRSA-established Community Health Applied Research Network (CHARN). The primary goal of this PCORI-funded intervention study is to evaluate the impact of a sexual orientation (SO) and gender identity (GI) data collection training for Community Health Center (CHC) staff on health outcomes for sexual and gender minority patients (SGM).
Health center data from all 12 sites over the 3-year study period, informed by HRSA’s Uniform Data Systems standardized reporting system that provides consistent information about health centers and look-alikes, has now been collected. We are currently analyzing the post-intervention data to assess whether the intervention affected health outcomes for SGM patients. Key informant interviews with CHC staff are being analyzed to determine barriers and facilitators associated with collecting SOGI data. Post-intervention survey data collection from CHC patients is nearly complete and these data will be compared with pre-intervention survey data in order to explore whether the intervention impacted SGM and non-SGM patients’ health care experiences.
We empower our clients to live better lives by engaging with them to create practical, workable strategies to reduce their risk of HIV infection. We also assist clients with getting tested for HIV and obtaining medical care, housing, and access to benefits offered by state and federal agencies. As a result, our clients are more likely to know their HIV status, connect with the health care system, and keep themselves and their families safer from HIV infection.
AIDS Action works to support people living with HIV/AIDS, improving their quality of life and increasing treatment adherence, which helps their individual health and the broader public health by reducing the likelihood of transmission. AIDS Action provides a comprehensive set of services for People Living with HIV in order to support their access to medical care and help them achieve HIV viral suppression.
Clients
were living with HIV/AIDS
As one of several state-sanctioned and state-funded syringe exchange programs in Massachusetts, the Access Drug User Health Program distributes and exchanges syringes to people who inject drugs. Access Drug User Health Program is one of the state’s pilot sites for the distribution of Narcan, a nasal spray provided to IDUs and their network of supportive family and friends to reverse potentially fatal overdoses.
Starting in early December the Access Program has started to pilot a low barrier medical clinic to offer wound care, treatment for Hepatitis C and other STIs, linkage to nPEP/PrEP, linkage to medication assisted treatment and more. The clinic is currently open twice weekly (Wednesday and Friday 9-12) and offers walk-in availability.
Below are the current service offerings available at Access Drug User Health:
Sterile syringes distributed
Used syringes collected
overdoses reversed and lives saved through Naloxone distribution
We deliver HIV, hepatitis C, and STI confidential testing and counseling services within our targeted prevention programs. During fiscal year 2021, we conducted 1,027 HIV tests among men who have sex with men (MSM), transgender and non-binary people, and people who inject drugs. We identified 5 new cases of HIVand reengaged 64 previously diagnosed, out-of-care HIV positive individuals back into HIV medical care.
HIV tests conducted
The sexual health program provides testing and treatment for HIV/HCV and STIs (chlamydia, gonorrhea and syphilis) to men who have sex with men (MSM), transgender individuals and sexual partners of those populations. As part of our engagement process, we ran several virtual events during in FY2021 to highlight issues of testing and the use of PrEP, these included the “World AIDS Day ‘What to Expect When Getting Tested’” video event, the “Transgender Retreat,” and “PrEPped for the Holidays.”
Additionally, our Linkage to Care Coordinators help navigate newly identified HIV-positive individuals to medical care, reengage individuals who may have fallen out of care, assist with insurance needs, and more. Health Navigators provide PrEP (pre-exposure prophylaxis, an HIV prevention medication) education and help connect at-risk individuals to providers who can prescribe PrEP.
In fiscal year 2021, 76 clients were provided PrEP adherence support and the program was able to engage 531 MSM under 30, one of the groups at highest risk of becoming infected with HIV.
Stable housing is a critical factor in the success of people living with HIV getting connected to and staying in care. Housing staff support clients with housing search, rental and utility assistance, and housing stabilization support.
The Housing Search Program connects clients to a range of housing options, including transitional, permanent, congregate, and scattered site housing units. Our supportive housing programs provide subsidies and supportive services to families and individuals living with HIV who are exiting homelessness. The Rental Assistance Program delivers short-term emergency assistance to clients who face eviction or unaffordable housing, need assistance with move in costs and need assistance with high utility bills to avoid shutoff. In fiscal year 2021, we helped 832 households impacted by HIV move to stable housing or avoid homelessness through one or more of these housing options.
Number of households affected by HIV that the Housing program assisted (total clients)
Permanent client placements through
Housing Search and Advocacy
The Legal Services Department provides legal direct representation and legal advice in a variety of civil matters to people living with HIV/AIDS. In FY21, Legal Services took on 189 legal cases, which covered a wide range of client needs, including civil matters such as housing and rental disputes, public benefits, financial and end-of-life planning, and more. The goal of the department is to advocate for the legal rights of those living with HIV/AIDS throughout Massachusetts. We believe that access to legal services allows our clients to live healthier and safer lives.
Legal cases taken on by Legal Services in FY21
Youth on Fire is a program for homeless and street-involved youth, ages 14 – 24, which operates a safe and warm drop-in center that provides access to everything from hot showers, meals, and laundry to mental health and medical care and services. We also run a housing program that helps to get young adults off the streets and into safe housing situations so they can start rebuilding their lives.
187 homeless or unstably housed young people received services from Youth on Fire in fiscal year 2021. When the program was forced to temporarily close its drop-in center in 2020 due to COVID-19, they began offering virtual groups and connection to life-saving resources through information update regularly on their Facebook page as well as online and telephone outreach.
Young people received services from YOF in FY21
By publishing policy briefs, submitting public comment and testimony, writing op/eds, participating in media interviews, and joining coalitions in partnership with other institutions, Fenway Health staff and affiliated researchers and scientists engage in broad efforts to advance and disseminate LGBTQIA+ and HIV-related health policy research.
During fiscal year 2021, Fenway programs, publications, staff experts, and events were featured in nearly 3,300 news stories, including in outlets like:
Click a logo to learn more.
Our Fenway@50 virtual gala, celebrating the 50th year of Fenway Health, was held April 28, 2021. Due to the COVID-19 pandemic, we moved our signature events online for a very special evening celebrating our LGBTQIA+ community.
The evening was hosted by the fabulous Nina West of RuPaul’s Drag Race fame. It included a look back at some milestones from our first 50 years of community care, remarks from public health hero Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, and musical entertainment from Mel Fine, Neo Gcabo, and Fenway’s own FCHords a cappella group.
Over 560 people logged in to join us for this special community gathering. Together, we raised over $350,000 in donations and auction sales to support the life-saving services and programs at Fenway Health!
We would like to extend special gratitude to our sparkling host, Nina West and to Dr. Fauci for his meaningful remarks. We’d also like to thank Neo Gcabo, Mel Fine, and the FCHords for uplifting us with their voices, and our celebrity guests Roxane Gay and Big Freedia for their messages of encouragement. Thank you to our Sponsors, as always, for supporting Fenway in practicing community care.
During the event, we featured videos that highlighted Fenway’s work in research, trans health care, and youth services, as well as a special Fenway@50 timeline. You can watch and learn more below:
These lists reflect donors and volunteers for fiscal year 2021, July 1, 2020 – June 30, 2021.
Kaan Apaydin
Peggy Burns
Michelle Buse
David Do
Andi Genser
Katherine Hartley
Colin Patrick Hildenbrand
Morgan Hughes
Justin T. Isaac
Mohammad Jalali
Robb W. Johnson
MA Ladd
Raul G. Medina
Carrie Richgels
Carl M. Sciortino, Jr., MPA
Jennifer Swanson
Eli Wasserman
Brian Weiner
John C. Welch, DNP
Amanda Annis
Arunabh Arora
Clint Attebery
Thomas Barth
Richard Blank
Edward Boyer
Doc Cesmebasi
Ross Cooper
Ken DeBlois
Roberta K. Eriksen
Philip Finch
Timothy J. Fitzgerald
Niamh C. Foley
Matthew Gibson
Monique Girard
Warren Green
Eric Greenberg
Catherine A. Grossi
Nicholas Hoover
Clarice Johnson
Ian W. Johnson
Ben Kudler
Barron Lambert
Cei Lambert
Ken A. Levine
Nachiket Londhe
Aaron Malgeri
Kristen McIntire
Matthew J. McNeff
Malinda J. McPherson
Roland Merchant
Laura O’Neil
Emmett Patton
Jeff D. Pike
Jane D. Powers, MSW, LICSW
Brian Powrie
Valentina Rosa
David J. Russo, Jr.
Robert Santiago
Melissa Savage
Abdel Sepulveda
Erina Spiegelman
Julia Spiegelman
Jeffrey Sulloway
Guru Swamy
Mark Vogel
Parker Wellington III
Donnie Worth
Zeming Yang
Michael Yeh
The 35th Annual AIDS Walk & Run was held virtually on October 18, 2020 do to the COVID-19 pandemic. While we missed being able to take it to the streets in person, we had a tremendous turnout for the online event (you can access the recording of the Walk here), which included incredible guest speakers such as Fenway Health’s CEO Ellen LaPointe, Boston Mayor Marty Walsh, and Congresswoman Ayanna Pressley—who was the 2020 Bette Byrnes Award recipient (click here to watch her acceptance).
For the FY21 Walk/Run, we invited all participants to walk or run 3.1 miles right in their own neighborhoods. We were joined by 343 amazing and dedicated supporters who helped raise $220,000 to support the vital work of Fenway Health and AIDS Action to fight HIV and help those living with or at risk of contracting this horrible disease.
These fundraising efforts would not be possible without both corporate and individual participants. Leading fundraising teams like Dunkin’ Brands’ Team INspire, not only raised $13,794, but also served as our Official Breakfast Sponsor and donated gift cards to each of our participants. Other top fundraising teams included The Ragon Institute of MGH, MIT, and Harvard ($56,424), John’s Team ($28,913), Vertex Pharmaceuticals ($20,030), and the Fenway Family ($8,047). The top five individual fundraisers in 2020 were Bruce Walker, Inez Folsom, Joshua Boger, Amy Boger, and Jonathan Urbach.
GOLD TEAMS
The Ragon Institute
John’s Team
Vertex Pharmaceuticals
INspire Dunkin’ Brands
Fenway Family
SILVER TEAMS
Alnylam
North Shore Walks for Verny
Schreiberian Running Club
BRONZE TEAMS
Beth Israel Deaconess Medical Center
Bill Adams
Saket Agarwal
Helene S. Bednarsh
Joshua S. Boger, PhD and Amy Schafer Boger, MD
Christine Bricault
Francisco Castro and
Richard D. McCarthy
Ross Condit
Linda L. Cotter-Cranston and Scott W. Cranston
Kimberly P. Cummings
Brian Derrick
Amby Drake
Jonathan Farley
Niamh C. Foley
Inez D. Folsom
David S. Fontaine
Lauren J. Gabovitch and
Bill Gabovitch
Sharon Glasser
Nancy L. Goldberg
Gordon M. Gottlieb
Morgan Grenier
Jim Haber
Bryan Horgan
Pete Jensen
Julie E. Kaufmann
Peter Konrad and
Shaun Watson
Kristen J. Lascoe
Helder Lemos
Brian Liberge
Eileen MacDougall and
Brian T. MacDougall
Jonathan A. McIntyre
Chad Michael and David Michael
Margret O. Nelson and Andrew W. Nelson
Allison P. Newman
Patricia A. Nichols-Cordero and Andrew P. Cordero
Shaun Noone
Isabella O’Connell
Kathryn Price and Tim Price
Gregory Rayo
Louise B. Rice and Tess Ewing
Arnold E. Sapenter and Joseph C. Reed, PhD
Ann E. Schlesinger
Warren M. Schur
Dawnmarie Simpson
William C. Smaha
Annie Smith
Jennifer Tran
Rita T. Tries and
James H. Tries
Jonathan M. Urbach
Joseph D. Vogel
Bruce D. Walker and
Alice M. Cort
While the 2020 Taste of the South End was held virtually, we had an incredible event that was supported by over 200 people who purchased tickets and tuned in to help raise over $82,000 to support Fenway Health and the communities we serve.
While it would have been delicious to gnosh together in person at the Cyclorama, it was delightful to celebrate the “Taste” community online. The event program featured a thank you to our donors from our host committee co-chairs Michelle Losasso and Donna Venegas, CEO Ellen LaPointe joined us to introduce herself to the Taste of the South End community, and The Sisters of Perpetual Indulgence spiced up the evening and added some off-color cheer.
It wouldn’t be a Taste of the South End unless we were joined by some of Boston’s finest chefs and restaurants. Joanne Chang of Flour and Myers and Chang was on hand, along with several other celebrity chefs including Chef Michael Lombardi of SRV, Chef Jimmy Liang of Fuji, Chef Alima of Haley House, and Chef Douglass Williams of MIDA who each presented cooking tutorials of some of their favorite dishes. Last, but certainly not least, while we couldn’t be together to share a meal in-person, several of our Taste restaurant partners provided exclusive one-night-only discounts to help celebrate the evening.
Please be on the lookout for more information regarding Fenway’s 2022’s new events!
Michelle Losasso
Donna Venegas
Darrell Smith
Anoush’ella
Aquitaine
B&G Oysters
Banyan Bar + Refuge
Bar Lyon
Bar Mezzana
Barcelona South End
The Beehive
Blackbird Donuts
Black Lamb
Boston Chops South End
Brownstone
Burro Bar
The Butcher Shop
Cinquecento
Cosmica
El Centro
Fazenda Coffee Roasters
Five Horses South
Flour Bakery + Café
FoMu
Formaggio Kitchen South End
Frenchie
Fuji at Ink Block
The Gallows
Gaslight Brasserie du Coin
Haley House Bakery Café
Masa Latin Kitchen + Tequila Bar
Mela Modern Indian Cuisine
Metropolis
MIDA
Mistral
Myers+Chang
No Relation
Orinoco
Picco
Sally’s Sandwiches
Shore Leave
South End Buttery
SRV
Clarke Living
Eastern Bank Foundation
EverQuote
FMC Ice Sports
Pfizer
Venegas and Company LLC
Coldwell Banker Cares, Inc.
Eaton Vance Management
Flour Bakery & Café
Gilead Sciences, Inc.
InterSystems
MedMinder
Meyers & Chang
OpenTable
Covelle & Company
Harvard Pilgrim Health Care, Inc.
New England Home Magazine
US Bank
Diageo
Martignetti Companies
Sam Adams & Truly Hard Seltzer
Boston Globe
Boston Spirit
Dig Boston
Edible Boston
Edge Media Network
Al Jones Collection
Jonathan Matsui, PhD
CHAIR
Diane M. Tucker
VICE CHAIR
Scott Walker, CFA
TREASURER
Trevor Z. Boylston
CLERK
Benjamin Davis, MD
David J. Davis, RN
Harold du Four-Anderson, M.Ed, LADC I
Roxane Gardiner, MD, MPH, MSHPEd, DSc
Colin Gibbons, MHA
Guadalupe Hayes-Mota, MBA, MS, MPP
Mikhaela Houston
Jennifer L. Jones
Michael A. Kramer, DDS, DMSc
Seth Levenson
Lisa L. Paine, CNM, DrPH
Amy Rasimas, MBA
Bianca Robinson, MBA
Betsy Smith, PsyD
Vincent C. Smith, MD, MPH
Joblin C. Younger, Esq.
Jonathan Matsui, PhD
CHAIR
Diane M. Tucker
VICE CHAIR
Scott Walker, CFA
TREASURER
Joblin C. Younger, Esq.
CLERK
Trevor Z. Boylston
Robert Chambers
Jennifer Chrisler
Benjamin Davis, MD
David J. Davis, RN
Harold du Four-Anderson, M.Ed, LADC I
Roxane Gardner MD, MPH, MSHPEd, DSc
Colin Gibbons, MHA
Lillian Gonzalez, CPA, MST
Guadalupe Hayes-Mota, MBA, MS, MPP
Mikhaela Houston
Jennifer L. Jones
Michael Kramer, DDS, DMSc
Amy Rasimas, MBA
Betsy Smith, Psy.D
Vincent C. Smith, MD, MPH
The Board of Visitors’ mission is to heighten Fenway’s visibility and provide additional expertise and experience to support the organization and its work. Fenway’s Board of Visitors members are interested and influential members of the community, patients, donors and friends. Ryan Gosser was the Chair of Fenway’s Board of Visitors.
Godwin C. Aduba
John N. Affuso
Karen Akunowicz
Jacob Andrus
Mikki Ansin
Christopher R. Arrington
Robin A. Atlas, MD
Steven Auerbach
Ashley L. N. Banfield
John H. Basile
Jeffrey Blackwell
Mara Blesoff
Casey Brown
David W. Brown
Taylor Brown
Bryan Bryson
Catherine D. Burgess
James C. Buttrick
Leah C. Camhi
Richard B. Carey
Alexandra Chandler
Stewart B. Clifford, Jr.
Harry R. Collings
Gillian Comito
John M. Costello
Deborah A. Daccord, Esq.
Gary K. Daffin
David M. Datz, Esq.
Katelyn Dolan, PT, DPT
Jeffrey P. Dugan
Steven P. Dyer
DeeDee Edmondson
Meryl Epstein
Thomas P. Evans
Daniel E. Ferrell
Philip Finch
Timothy J. Fitzgerald
Arlene Fortunato
Steven F. Fossella
Isabella M. Gambill
Ryan Gosser*
A.J. Goulding
Jack Gronau
John A. Haas
Cyrus Hamer
Eugenia Handler
Cynthia Harmon
Taylor S. Harris
Charlie R. Hindmarsh
Andy Huang, CPA
Justin T. Isaac
Maxine Jackson
John B. Koss, Esq.
Michael Kozuch
Matthew D. LaBrie
Mary Landrigan-Ossar
Ted T. Lee
Stephanie Letzler
Bruce A. Lewis
Rhonda J. Linde
Jonathan S. Litt, MD
Michael Lowenthal
Paul E. Lynch, MD
Matthew W. McGuirk
Michael E. McHugh
Mary Beth McInerney
Raul Medina
Leif Mitchell
Lindsey L. Noecker
Bisola O. Ojikutu, MD, MPH
Rev. Fr. Alex Oneto
Dale Orlando**
Liz Page
Jennifer Petter
Jay Philomena
Elizabeth Pilgrim
John R. Pitfield, Esq.
Bryan C. Pridgen
Brian Ramos
Angela L. Rappoli
Ms. Gena Ricciardi
Louise Rice
Glenn A. Rigoff
Alessandra R. Robinson
Carol A. Roby
Jonathan S. Rotenberg
Arnold E. Sapenter
Regina Savageau
Sarah Schochet
James R. Seligman, DMD
Douglas W. Spencer
Richard Spencer
Caleb Paul Stewart
Dr. Adam M. Tobias
Paul B. Toomey
Teresa Trammell
William M. Webster
John C. Welch
Matthew Wilder
Claire B. Willis, LICSW
Michael T. Wong
Brady Wyrtzen
Cristina Yordan
Richard J. Yurko
David Zimmerman
Stephen H. Zinner, MD
*Chair
**Deceased
The following companies and foundations generously support Fenway Health’s mission. Whether through their event sponsorship, targeted support of specific programs or services, or general support, Fenway is truly grateful to have these partners in support of the care we provide.
The Boston Foundation
Commonwealth Care Alliance
Direct Relief
Eugene M. Lang Foundation
Fidelity Foundation
Gilead Sciences, Inc.
Harbor To The Bay Inc.
Income Research + Management Charitable Fund
Liberty Mutual Foundation
Massachusetts League of Community Health Centers
RIZE Massachusetts
Broadway Cares, Inc/Equity Fights AIDS
Takeda Pharmaceuticals
Tikkun Olam Foundation, Inc.
Anonymous
American Tower Corp.
Biogen Idec Foundation
Blue Cross Blue Shield of Massachusetts Foundation
Boston University
Consumer Medical
Eastern Bank Foundation
Elizabeth Taylor Foundation
The Hamilton Company Charitable Foundation
Henry J. Kaiser Family Foundation
Janssen Products, LP
Karyopharm Therapeutics, Inc.
Macy’s Foundation
Moderna
Project Bread
PwC LLP
Santander Bank
The Bernard and Anne Spitzer Charitable Trust
Wistia
Alexion Pharmaceuticals, Inc.
Alnylam Pharmaceuticals
Apple
The Susan A. and Donald P. Babson Charitable Foundation
The Bennett Family Foundation
Berkshire Bank Foundation
Boston IVF
Cambridge Community Foundation
Cambridge Savings Bank
Eaton Vance Management
Joy in Childhood Foundation
The Kessler Family Foundation
KPMG
Locke Lord LLP
People’s United Community Foundation of Eastern MA, Inc.
Robert Lloyd Corkin Charitable Foundation
Rockland Trust – Blue Hills Charitable Foundation
Ropes & Gray LLP
TD Charitable Foundation
Tufts Health Plan
Venegas and Company LLC
Vertex Pharmaceuticals, Inc.
Walgreen Co
Woolley-Clifford Foundation
AAFCPAs
athenahealth
BNY Mellon
Boston Evening Clinic Foundation
Brown Brothers Harriman
CareAcademy
Cityside Subaru
Deloitte & Touche USA LLP
Dowling & O’Neil Insurance Agency
Forest Foundation
Janssen Therapeutics
Law Office of Joblin C. Younger, P.C.
MassMutual Financial Group
The MENTOR Network Charitable Foundation
MLS Property Information Network, Inc.
New England Homecrafters, Inc.
Performance Northeast Services, LLC
Quest Diagnostics
Sacajawea Charitable Foundation
Tufts University
Wellington Management Company, LLP
Amazon Smile
Art 4 Health
The Barrington Foundation, Inc.
Bessemer Trust
Citizens Bank
Consulate of Canada – Boston
Cummings Properties, LLC
First Church Somerville UCC
Friends Meeting at Cambridge
Hae Ahm (Sea Rock) Foundation
John Hancock Financial Services
MFS Investment Management
Premier Martial Arts – Stoughton
The Royal Commonwealth Society Inc.
Sappi North America
The Society of Saint John the Evangelist
Tufts Health Plan Foundation
UMass Overwatch
United Way of Massachusetts Bay & Merrimack Valley
Ameriprise Financial
Combined Jewish Philanthropies
Entegris Inc.
Flour Bakery & Cafe
Gartner, Inc.
GLBTQ Legal Advocates & Defenders
JSP Family Foundation
LGBT Elders of Color
LitmanGerson Associates, LLP
Loomis, Sayles & Company, LP
Mennonite Congregation of Boston
Microsoft Giving Campaign
Nuance Communications
PayPal Gives
Planned Parenthood League of Massachusetts, Inc.
QurAlis Corporation
RepTrak
Second Street Associates, LLC
The following lists reflect donations made to Fenway Health and AIDS Action during fiscal year 2020, July 1, 2020 through June 30, 2021.
Mary C. Jigarjian and George Jigarjian
John M. DeCiccio
Shaun P. McMahon
J. Scott Walker
Godwin C. Aduba and Tim Byrne
Steven Auerbach and Mark Scofield
Joshua S. Boger, PhD and Amy Schafer Boger, MD
Raphael Jaimes-Branger and Eliot T. Wright
Betty I. Morningstar and Jeanette Kruger
Anne M. Peterson and Mark A. Peterson
Kevin P. Wulff
Anonymous (2)
Gregory D. Ansin
Ashley Banfield and Emily Drahzal
James C. Buttrick
James E. Canales and James C. McCann, MD
Pamela D. Choney and Jeffrey A. Choney
Stewart B. Clifford, Jr.
Steven D. Corkin and Dan Maddalena
John R. Ehrenfeld and Ruth R. Budd
Nicholas Everage, PhD
A.J. Goulding and Jason Huang
Lori J. Griffiths and Family
Matt Gromada and Javier Lopez-Molina
Patrick C. Guerriero
Paul Hempel
Joanne Herman and Terry Fallon
Thomas M. Kennedy
Matthias D. Maguire
Mary Beth McInerney and Susan Barclay
Jeffrey B. Meaney
Brian T. Mitchell
Jeffrey H. Munger and Robert T. Whitman
Daniel S. Newton and Christopher L. Flynn
Ernest J. Pusateri
Louise B. Rice and Tess Ewing
Sarah Schochet and Darrah March
Andrew Sigel
Kathleen A. Tucker
Ann M. S. Wiencek and Paul R. Wiencek
Eddie Zaidner, MD
Yijie Zhang, PhD
Karina Bercan
Joseph Castellana, PhD and
James R. Seligman, DMD
Brian P. Cooper, PhD and
Margueritte S. Murphy, PhD
Marco A. DeThomasis
Stephen C. Harrison and Tomas Kirchhausen
Kenneth F. Hirschkind
Ellen Hurvitz and Barry Strasnick
Lorraine Jones and Elizabeth Halstead
Peter F. Jones and Wayne G. Gaffield
Kenneth W. Kendrick, Jr.
William W. Kimball
G.P. Paul Kowal
Mary Landrigan-Ossar, MD, PhD and Jacob Ossar
Jillian Levine and Sherry Cheuk
Mark H. Libenson, MD and Lisa M. Muto, PhD
Raul G. Medina and Bradley Ursillo
Renee L. Miltz
Michael J. Piore and Rodney L. Yoder
Brian Price, MD and Paul D. Anagnostos
Joseph T. Realmuto, Jr.
Michael L. Reney and Alexander Cruz
Paul and Carol Rose
Craig M. Sato and Joseph J. Takarewski
Charles Steenburg
Caleb Paul Stewart
John C. Welch, DNP
John F. Winterle, DMD
Joblin C. Younger, Esq.
Jose R. Zorola
Anonymous (3)
John N. Affuso
Ceceilia Allwein
Gary Bailey, MSW
The Barrington Foundation
Michael J. Barry, MD and Jean W. Barry
John H. Basile
R. David Beck and Gregory R. Van Boven
Kathleen R. Beckman and Theodore Postol
Steven H. Berez
James M. Bonanno, MD and John J. Cormier
Mohan D. Boodram and Robert F. Morris
Michael and Jennifer Borislow
Armene A. Boyajian
Trevor Z. Boylston
William H. Brack and Jessica A. Ladd
The Honorable David J. Breen and
Michael R. Harrington
Margot H. Brickelmaier
William B. Brockman and Lucy E. Hadden
Randy Broomhall-Dillard, PhD
Graham T. Brown
Robert L. Buckwalter
Joseph M. Cacciola and
Thomas G. J. Trykowski, AIA
Dr. Christopher L Campion & Jason M Vellen
Richard B. Carey
Robert M. Caro
Stewart and Patricia Chapin
T. Coletti
Dennis E. Condon and Robert J. Cummings
Lance W. Connolly and Kelly Connolly
Jeff A. Conrad
Zachary Coseglia and Benjamin Soisson
Deborah A. Daccord, Esq.
David J. Davis and Tracy Thompson
Frederick J. Doherty
Harold du Four-Anderson
Peter J. Epstein, Esq.
Thomas P. Evans
Raymond Faulkner and Carlos M. Terra
Valerie and Jacqueline Fein-Zachary
Dena B. Feldstein and Edward Brody
Philip Finch and William Halpin
Lindsey Flanagan
Theodore L. Fleming and Kathryn B. Fleming
Arlene Fortunato and Darcy Pfeifer
Domenic Gaeta
Janet and Andrew Gainer-Dewar
Clifton A. Gaskill
Robert L. Geary
David A. Georgantas
Tracy Germann
Cynthia M. Goncalves and Shane A. Depina
Alex Gonzalez, MD, MPH
Anne K. Goodman
Mia Gore and Abraham Gore
Mary L. Gray
Don and Mary Green
Anthony Grillo
Edward M. Gromada and
Madeleine T. Gromada
Mark L. Guenard
Ross Harpestad
Taylor S. Harris
Timothy B. Harwood
Guadalupe Hayes-Mota
Deborah Heller, PhD and Ann Sanders
Stephen J. Hendrickson and David McCord
Timothy T. Hilton
John S. Hoag
Peter E. Hornstra
Derek A. Howe and Brian S. Galloway
Andy Huang
Matthew Jemison
Wendy E. John
Ian W. Johnson
Jennifer L. Jones
Catherine Kapadia
Todd A. Katzman and Marc Lacasse
Richard Kovalcik
Jill Kowal
Ellen LaPointe and Jen Cross
Ted T. LeeDiane K. Lincoln
Derek R. Lisinski
Jonathan S. Litt, MD
Clarence R. Lyons
Lucy Mack
Ryan MacLean
Edmond R. Macri
Thomas J. Martorelli
Christine Matsui and Jerold Matsui
Jonathan I. Matsui, PhD and R. Bryan Smith
Kenneth H. Mayer, MD
Michael E. McHugh
Robbie J. Meitler
Daniel A. Michaud, MPA and Brice Booker
Neal Minahan and Eric Archibald
MaryAnn Moskofides
Jess Muskin-Pierret
John E. Paap and Mary L. Paap
Liz Page and Marianne Stravinskas
Lisa Paine, CNM, DrPH and Linda Daniels, PsyD
Samuel Pang, MD and Andrew Pang
Stephen P. Pentek
Benjamin D. Perkins and David W. Brown
Brian K. Perry and Kevin Crawford
Kevin Peterson
Jennifer and Catherine Petter
Michael Pickard
John R. Pitfield, Esq. and Paul E. Lynch, MD
Tina M. Pittore
David J. Poorvu and Nancy Poorvu
Jenny Potter, MD and Joyce L. Collier
Jane D. Powers, MSW, LICSW and
Margaret M. Hayes
Michael E. Profenno
Rick Redmond
Joey Riddle
Lewis Rieley and Bryan Barbieri
Glenn A. Rigoff
Louis F. Risoli and Charles B. Fisk
Bianca Robinson, MBA
William B. Rubenstein
Arnold E. Sapenter and Joseph C. Reed, PhD
Dorothy A. Savarese
Glenn A. Seberg
Ellen Semonoff
Diane Sidorowicz and Lourdes Rodriguez
Michael Skrip and James M. Brown
Gary R. Sloper
Cornelia E. Smith and Berit Pratt
Vincent C. Smith, MD, MPH
Naomi Sobel and Becky Silverstein
Douglas Spencer
Sally A. Stalker
Blaze A. Stancampiano
Dan Sugalski
Joseph Sullivan III and Jay Qu
Christopher Sutherland and Steve Quezada
James M. Sweeney
Deb G. Taft and Terri L. Rutter
Peter Tenggren and Warren Mitchell
Hal Tepfer and Stacie L. Simon
Vic Terawskyj
Mark E. Toney and Daniel J. Hartigan
Diane M. Tucker
Leigh J. Tucker and Stephen R. Mehrtens
Kevin J. Tully
Dorothy A. Van Ryzin
Joseph C. Veneto
Lenore Von Krusenstiern
Thomas P. Webber and Keith J. MacDonald
Becky Weidenbruch and John Weidenbruch
Martha L. Wengert and Laura E. Dorfman
Kim Williams and Trevor Miller
John P. Wolfarth and Kevin W. Powers
Michael T. Wong, MD
Stephen H. Zinner, MD
Michael F. Zito
Robert Zverina and Kathy A. Spiegelman
Anonymous (4)
Jonathan B. Aibel and Julie I. Rohwein
Jazzmine Arbuthnot
Jesse Baerkahn
Julie E. Bailit and Michael H. Bailit
Karl A. Basile and Charles T. Oden
Kenneth J. Bazydola and Sarah M. Bazydola
Kaytie Beasley
Emily Beinecke
Jerry M. Bernhard
Ilouise Bradford
Carol J. Bresler and Carolyn A. Billinghurst
Carson Burrington
Patricia J. Caldwell and Richard L. Connolly
Leah C. Camhi and Amy A. Pitter
Juliet Carey, MPH and Barbara Parton
Alexander G. Carlock
Roger M. Carter
Martha J. Cutting and Frank J. Cutting
André and Marilyn Danesh
Norman R. Daoust
John D. Degnan
Cecelia A. DeMarco and Anne M. Campbell
Katelyn Dolan, PT, DPT
Peter J. Dominski
Karyn Donahue
Mark J. Duffy
Steven P. Dyer
George P. Edmonds III and Athena Edmonds
Leif W. Ellisen, MD, PhD
John W. Erickson and Michael E. Field
Paul W. Ernest and Camille G. Ernest
Kimberly T. Erwin
Gary Fallas
MK Foley
Niamh C. Foley
Jason Fox-Reardon
David Ganak and James Sargent
Michael J. Gillespie and Paul Braswell
John W. Gintell and Robert S. Coren
Frank V. Graziano and Jennifer A. Graziano
Lisbeth J. Hall
Megan Hall and Honor MacNaughton
Matthew Hamilton
Sarah E. A. Hanselman and Eric G. Hanselman
Christina Heinrich
Donald Heinrich
Clinton A. Heitman
Richard Higger
Anita L. Huggins and Norman W. Huggins
Gilbert L. Huppert
Alan H. Ingram, Jr.
Fern L. Johnson and Marlene G. Fine
Elizabeth Kass, MD
Jeffrey A. Kramer
Michael A. Kramer, DDS, DMSc
David A. Kronman
Ronald V. Lacro and Jon P. Schum
Richard Lerner
Jonathan Li
Daniel A. Lowen
Eva Lundsager
William T. Lynch and Ingrid G. Larson
Michael Malafronte
Shibin Mathew
Zachary D. McCabe
Theresa M. McLaughlin
Malinda J. McPherson
Michael Meidinger
Matthew Metivier
Andrew Meyer and Anthony Fallon
Robert F. Monaco
Sarah S. Nielsen and Dana B. Nielsen
Lindsey L. Noecker
John T. O’Keefe and Mark D. Smith
Faith K. Parker and Glenn P. Parker
Hayley Parker
Elizabeth C. Parsons
Christopher Perrotti and Taice Perrotti
Monika Pichler
Wayne B. Powell
Moose Price
The Racemaker Charitable Fund at The Chicago Community Foundation
Abram Recht and Martha Recht
Valentina Rosa
Jon Z. Rosbrook
Michael Rotenberg and Karen S. Rotenberg
Catherine N. Ryan
Steven Salerno and Adrianne Seiler
Fillip Saraiva
Defne Sastim
William J. Sawyer and Pamela P. Sawyer
Carole Schlessinger
Lyn Shamban
Zachary Shearn
Luther W. Smith
Mary G. Smith and Simone Reagor
Pamela A. Smith and Steven E. Thomas
Ryan Smith and Dante Ramos
Wendy Stead
David Strichartz and Collenne Strichartz
Anna Tanabe-Robichaud
Fred M. Taylor
Stephen Thrush
Steven J. Tromp
Robin F. Verdier
Corinne Vien
Richard Voos
James C. Wadleigh
Cathy L. Walker
William M. Webster and Jeffrey P. Dugan
Irene M. Weigel and Lynn B. Weigel
Scott R. Wilson
George D. Wright IV
David Wypij and Timothy M. Baum
Anonymous (14)
Carole J. Aaron
Michael Achey
Beverly and Nellie Adams
John H. Adams
Eve Adler and Scott Groper
John N. Affuso
Jonathan B. Aibel and Julie I. Rohwein
Michael S. Albert
Larry Albertson
Philip J. Allessio
Kenneth M. Aloisi
Frances Ames and Maureen Dubois
Martin R. Anderson
Amanda Annis and Guillermo Velasco
Gregory D. Ansin
Mikki Ansin
Jonathan S. Appelbaum, MD and William D. Morowski
Tammy L. Arcuri, Esq.
Katharine B. Arnstein
Paul B. Atwood and Rebecca H. Atwood
Paul A. Auerbach and Nancy D. Auerbach
Pierre F. Auger and Jill F. Auger
David N. Aurelio
James Aurelio
Robert P. Babineau
Julie E. Bailit and Michael H. Bailit
Raymond L. Barnes
Joseph P. Barri
The Barrington Foundation
Michael J. Barry, MD and Jean W. Barry
John H. Basile
Iain G. Bason
Bev Bates and Chris Connors
Kenneth J. Bazydola and Sarah M. Bazydola
R. David Beck and Gregory R. Van Boven
Bettina Beckman and Ronald J. Castile
Kathleen R. Beckman and Theodore Postol
Sally Beecher and Harold M. Moren
Peter P. Belobaba
Alan R. Bender
Adrienne R. Benton
Steven H. Berez
Jerry M. Bernhard
Marilyn Bernstein
Alden J. Bianchi and Mary E. Kett
Philip C. Bibb
Leisa D. Binette
Jeffrey Blackwell
Elizabeth M. Blaicher
Arthur R. Blake
Eleanor M. Blakeney
Michael A. Blau and Dianne A. Blau
Nora Bloch
Stephen J. Bobrinitz
Edward S. Boesel
Joshua S. Boger, PhD and Amy Schafer Boger, MD
Carrie Bolster
James M. Bonanno, MD and John J. Cormier
Bruce P. Boni
Mohan D. Boodram and Robert F. Morris
Jennifer T. Borhegyi and George L. Borhegyi
Michael C. Borislow and Jennifer A. Borislow
Debra K. Borkovitz
Jennifer M. Boyle and Christopher Rowley
Trevor Z. Boylston
Billie R. Bozone
William H. Brack and Jessica A. Ladd
Stephen P. Bradley and Edeltraud D. Bradley
Peter J. Brady and Alan Davis
The Honorable David J. Breen and Michael R. Harrington
Gary B. Brenner
Carol J. Bresler and Carolyn A. Billinghurst
Margot H. Brickelmaier
Judith H. Briss
Randy Broomhall-Dillard, PhD
David W. Brown and Benjamin D. Perkins
Kevin Brown
Kristine P. Brown and Scott P. Brown
Kenneth A. Bryant and Diane J. Bryant
Wayne M. Bryant and Maryann Grenier
Robert L. Buckwalter
Richard J. Buirkle
Sherry Burke
Steven and Helen Burns
Susan O. Bush
James C. Buttrick
Paul Buzzell
Joseph M. Cacciola and Thomas G. J. Trykowski, AIA
Sean R. Cahill
Patricia J. Caldwell and Richard L. Connolly
John and Annette Campbell
James E. Canales and James C. McCann, MD
Arthur A. Canter and Gary R. Brissette
Leon Cantor and Jayne E. Cantor
Joseph R. Caputo and James W. Hanosh
R. W. Card
Juliet Carey, MPH and Barbara Parton
Joseph A. Carrese and Michele E. Beaulieu
Barbara J. Carrigg
Kirk and A. Price Carter
Melissa Carter
Roger M. Carter
Roger M. Cassin and Irma M. Schretter
Joseph Castellana, PhD and James R. Seligman, DMD
Michael A. Castellana and Robert Rothery
Kenneth F. Caulfield
Helen T. Chapell
Elyse D. Cherry
Christofer Chiappa
David P. Chicoine
Anne McAdams Chochrek and Joseph Chochrek
Pamela D. Choney and Jeffrey A. Choney
Nina F. Cimini
Anderson Clark, PhD
Dorie Clark
Jessica and Meredith Clemons
Janet A. Clifford
Stewart B. Clifford, Jr.
John Coakley
Laurie H. Cohen
Robert S. Cohen
Joyce L. Collier and Jennifer Potter, MD
Harry R. Collings and Daniel B. Moon
Jane L. Collins
Dennis E. Condon and Robert J. Cummings
Michael and Louise Connelly
Lance W. Connolly and Kelly Connolly
Jeff A. Conrad
Michael G. Conway
Barry B. Corden
Steven D. Corkin and Dan Maddalena
John M. Costello
Peter B. Coughlin
Paul L. Coulombe
Marsha L. Cramer and Michael Cramer
Harold S. Crowley
Teresa H. Crowley and Daniel J. Crowley
Gabrielle M. Cunningham and Carl J. Cunningham
Tom Daccord
Arthur Dahl
Joan C. Dalto and Edward A. Dalto
Lisa Dames and Barry N. Wilensky
André and Marilyn Danesh
Jessica L. Daniels
Norman R. Daoust
Philip R. Daoust
Diane Davidson and William Weidacher
Marc J. Davino
David De Rosier and Esta DeRosier-Markin
Grace E. Deasy
John M. DeCiccio
Emily R. DeMelo
Edward J. DeMers
Donald E. Denniston
William P. DeRosa
David F. DesLauriers and Kevin Durand
Marco A. DeThomasis
Mary L. Dill
Frederick J. Doherty
Peter J. Dominski
Laura E. Dorfman and Martha L. Wengert
Brenda Doyle
Margaret E. Doyle
Mark J. Duffy
Nan Dumas
Frank M. Dunn and Sheila Condon
Michael Duttlinger
Steven P. Dyer
Lee Edelman and Joseph Litvak
George P. Edmonds III and Athena Edmonds
John R. Ehrenfeld and Ruth R. Budd
Andrew Q. Ellingson
Leif W. Ellisen, MD, PhD
Stephen J. Engler and John S. F. Lopes
Leonard A. Epstein and Diane L. Clark-Epstein
Linda F. Epstein
Peter J. Epstein, Esq.
Paul W. Ernest and Camille G. Ernest
Kimberly T. Erwin
Donald H. Eunson
G. Douglas Evans
Thomas P. Evans
Willie Evans
Kyle Y. Faget, Esq.
Brian Falvey
Gail D. Fanning-Grove
Susan E. Faris and Charles Faris
Randal Farrar
Sally Farrell
Michael T. Fatale
Teresa L. Faulisi
Raymond Faulkner and Carlos M. Terra
Valerie and Jacqueline Fein-Zachary
Daniel E. Ferrell and David N. Rogers, Ed.D.
Jared A. Fijalkowski
Bruce W. Finch and Keith A. Reimann
Philip Finch and William Halpin
Renee Finn and Steven Finn
Arthur M. Finstein and Lois A. Finstein
Michael Fiorentino
Timothy J. Fitzgerald
Paul J. Flannery
Frank V. Fleming and Edward M. Fleming
Michael Flier and David Trueblood
J. Kevin Foley and Elaine K. Foley
Niamh C. Foley
Jelena T. Follweiler
Inez D. Folsom
David S. Fontaine
Arlene Fortunato and Darcy Pfeifer
Steven F. Fossella
Susan E. Foster and Bruce Horwitz
Victoria Fowler and Ileen Carrel
Kate Fractal
Paul M. Frascella
Victoria C. Fremont
Sally Friar, DC
Donna A. Friedman
Andrew M. Fullem
Russell Furtado and Charles Smith
Lisa S. Fusaro, MD and Maura Shaughnessy, MD
Philip A. Gambone
Roxane Gardner
Gina M. Gargano
Clifton A. Gaskill
Robert L. Geary
Jerry Gechter and Anne M. Gechter
Michael J. Gettings and Lars Lundgren, MD
Kathy A. Gianino and Alice M. Knowles
Paul B. Gilbert and Patricia C. Romeo-Gilbert
Sterling B. Giles
Robert W. Gill
Michael J. Gillespie and Paul Braswell
Arthur L. Gilman
Barbara E. Gleken
Cindy B. Goldstein and Roger N. Goldstein
Alex Gonzalez, MD, MPH
Andrew Goodman
Anne K. Goodman
Deborah R. Goodman
Robert Goodman
Gordon M. Gottlieb
A.J. Goulding and Jason Huang
Christina Grasso, MPH
Elizabeth W. Gray-Nix
Leona Green
Peter G. Green and Lucy A. Green
Michael and Arlene Greenstein
Robert L. Greenwald
Marcia N. Grey
Stephen A. Griffin
Lori J. Griffiths and Family
Carolyn Grillo and Erin Deadmon
John W. Grindrod and Janice M. Grindrod
Edward M. Gromada and Madeleine T. Gromada
Matt Gromada and Javier Lopez-Molina
Mark L. Guenard
Robert M. Guerin
Patrick C. Guerriero
Jim Haber
Joseph Haley and Eric Tingdahl
Lisbeth J. Hall
Philip K. Hamilton and Mary C. Hamilton
Michael Hammerschmidt
John D. Hancock and John F. Wood
Carolyn E. Hannauer
Susan R. Hansberry and Mitchell L. Hansberry
Dean T. Hara
Ruth E. Harcovitz
Robert S. Hark and Richard A. Berry
Stephen M. Harney
Ross Harpestad
Stephen C. Harrison and Tomas Kirchhausen
Carol Hartman
Mark A. Hayford
Alan S. Healy and Christina S. Healy
Susan Hegel
Deborah Heller, PhD and Ann Sanders
Paul Hempel
Neil F. Henderson
Robert J. Henry, MD
Mark A. Herdeg and Zane Kuchera
Gerard W. Herlihy
Joanne Herman and Terry Fallon
John E. Hershey and Anna S. Hershey
Marcie Hershman
Christopher P. Hesen and John W. Bethard
Marjorie R. Hess and Rudolph J. Talaber
Jeffrey J. Hickey and Christian F. Brocato
Luke R. Hill and Mary E. Driscoll
Charlie Hindmarsh
An G. Hinds
Kenneth F. Hirschkind
Sheilah M. Hoelscher and Melissa A. Stockbridge
Jane and Bradley Honoroff
Peter E. Hornstra
Roland P. Houde and Mary G. Houde
Robert E. Housman and Sue T. Housman
Derek A. Howe and Brian S. Galloway
Laura J. Howick and Dale J. Szczeblowski
Yanling Huo
Ellen Hurvitz and Barry Strasnick
Jan Hurwitz and Joan Seidel
Richard L. Iandoli, Esq.
Justin T. Isaac
Raphael Jaimes-Branger and Eliot T. Wright
Katherine A. Jantzen and Ronald Michaels
Herman C. Janzen and Gary A. Godin
Maria Jasin
Mary C. Jigarjian and George Jigarjian
Maurice P. Joffe
Wendy E. John
Deborah A. Johnson
Ian W. Johnson
Patricia A. Johnson
Peggy L. Johnson, MD and Koni Ross-Johnson
Robb W. Johnson and Richard J. Gosselin
Willard M. Johnson
Jennifer L. Jones
Peter F. Jones and Wayne G. Gaffield
George H. Joseph
Lionel S. Joseph
Marvin H. Kabakoff
James C. Kaddaras, Jr.
Minai Kam and Amy Murrett
Gary B. Kaplan
Leslie M. Kaplan
Elizabeth Kass, MD
Rob Kassel
Todd A. Katzman and Marc Lacasse
Susan Kaufman
Barry A. Kean
Terence M. Keane, PhD and Douglas H. Hughes, MD
James M. Keating
Susan Kelley and Peter Kadzis
John E. Keon and Claire T. Keon
Kathy L. Kerby and Benjamin Littauer
Mary Kercz and George R. Embleton
William W. Kimball
Jonathan R. King and James Stott
Susan F. Klein
Leslie C. Knapp
David E. Knudsen
Keith D. Kohl
Peter Konrad and Shaun Watson
Andrew W. Koppel
John Koss and Charlie Compton
G.P. Paul Kowal
Mary W. Kowit and Joel D. Kowit
Jeffrey A. Kramer
Michael A. Kramer, DDS, DMSc
Stanley Kramer
Ellen Kranzer
Linda J. Kraus and Thomas D. Kraus
Thomas E. Krueger
Ben Kudler
Karen F. Kupferberg
Ralph A. Kusinitz
John S. Kyper
Robyn Laing
Gerry O. Lake
David Lampariello, OD and James Summers, Jr.
Stewart J. Landers, Esq. and John Boyce
Peter A. Lans
Peter LaPlante
Gregory L. Larson and Stefanie K. Larson
Suzanne Lascoe
Lewis Lasher
Cathy J. Lavoie Griffin and Thomas W. Griffin
Janet Lawn and Maryann Chaisson
David E. Lefebvre and Amy LeFebvre
Seth L. Levenson and John Cunningham
Lorenzo Lewis, Jr., MD and Eva Schoenfeld
Mark H. Libenson, MD and Lisa M. Muto, PhD
Steven L. Lieberman
Diane K. Lincoln
John Lisker
Jonathan S. Litt, MD
Daniel and Deborah Lolik
Sue Lonoff de Cuevas
Jack Lottey and Frances Lottey
William E. Louie
Margaret A. Lourie
Daniel A. Lowen
Richard Lu
Kathleen A. Luvisi and Margaret Luvisi
Kristin K. Lynch
Malachy C. Lynch
William T. Lynch and Ingrid G. Larson
Peter Machinist and Alice R. Machinist
Lucy Mack
Robert W. Mack
Edmond R. Macri
Matthias D. Maguire
Diane L. Mahana
Susan Malspeis
Judith G. Mannheim
Melvin A. Manson
Michael Manthei and Benjamin Manthei
Elizabeth L. Marks and Paul A. Taylor
Mary and Alan Marshall
Rebecca and Carla Marshall-Waggett
Brian Martin
Lawrence A. Martin
Thomas J. Martorelli
Jonathan I. Matsui, PhD and R. Bryan Smith
Gal Mayer, MD
Kenneth H. Mayer, MD
Charles Mayo and Mary Ellen Mayo
Kimba R. McCant
Sean M. McConnell
Matthew J. McCormack and Kelly E. McCormack
Robert McDonald
Thomas E. McDonald
Kevin F. McElroy
John McGrail
Thomas McGrath
Lynda McGraw
Michael E. McHugh
Arthur P. McIntosh
Vinnette A. McKay
Andrew W. McKinley
Theresa M. McLaughlin
Joanne J. McLean
James H. McQueen
Matthew McTygue and Todd A. Rivers
Anne Meade
Jeffrey B. Meaney
Raul G. Medina and Bradley Ursillo
Robbie J. Meitler
George Mercier
Christiane E. Merrow
Myron Merrow
Daniel A. Michaud, MPA and Brice Booker
Laila J. Michaud
Neil Miller
Scott Miller and Lorraine Miller
Stephen Minicucci
Vicki E. Mistacco
Brian T. Mitchell
Thomas Mitchell
Robert F. Monaco
David L. Montanari and Sara L. Rubin
Lynda Morgenroth
James M. Morgrage
Betty I. Morningstar and Jeanette Kruger
Ruth E. Morris and Peter G. Kelly
Chad C. Mosca
Fredric A. Moscowitz and John T. Stella
Eva S. Moseley
Edmund A. Mroz and Celia B. Shapiro
Peter Muise
Robert Muller
James R. Mullin and Wendy K. Mullin
Kathleen M. Mundhenk and Charles F. Mundhenk
Jeffrey H. Munger and Robert T. Whitman
Zara and Janice Muradali
Florence M. Murphy
Kathleen M. Murphy
Joseph F. Murray
Robert Y. Murray
Margaret J. Murtagh
Carl D. Nagy-Koechlin and Beth Nagy
Margret O. Nelson and Andrew W. Nelson
Daniel S. Newton and Christopher L. Flynn
Dona L. Nicholas and Stephen Peckiconis
Patricia A. Nichols-Cordero and Andrew P. Cordero
Lindsey L. Noecker
Karen Norlin and Richard D. Norlin
Karen M. Norris
Peter A. Norton and Elizabeth H. Norton
Patricia T. Oakes
David Paul O’Brien
John T. O’Keefe and Mark D. Smith
Patrick B. O’Neal
Elizabeth E. Oppedisano
Roberta L. Orlandino and Brenda S. Gailhouse
Christopher Orlando
Susan P. Otis and Richard G. Foote
Constance L. Otradovec
John E. Paap and Mary L. Paap
Melissa Padley
Allison Page
Liz Page and Marianne Stravinskas
Lisa Paine, CNM, DrPH and Linda Daniels, PsyD
Robert H. Paisner and Elizabeth Paisner
Samuel Pang, MD and Andrew Pang
Marcia A. Parisi and Robert J. Parisi
Faith K. Parker and Glenn P. Parker
Elizabeth C. Parsons
Kunjal Patel
Robert P. Patten and Valerie A. Yarashus
Brian J. Pattullo and Raymond A. Brown
Kerry A. Payson and Mark H. Payson
Ann Pearson and K. Brook Herren
Theodore A. Peck III
Thomas D. Penque
Stephen P. Pentek
Nicholas Pepe
Ronald F. Peracchio
Roy D. Perdue
Judith E. Perlman
Brian K. Perry and Kevin Crawford
Stephen C. Perry and Oliver Radford
Anne M. Peterson and Mark A. Peterson
John J. Petrowsky and Thomas B. Vise
Rob and Elizabeth Phelps
George Phillips
Jay Philomena
Jeff D. Pike and John Kelly
Michael J. Piore and Rodney L. Yoder
John R. Pitfield, Esq. and Paul E. Lynch, MD
Tina M. Pittore
Joseph P. Poirier
Kristen E. Porter and Andrea Boyer
Jane D. Powers, MSW, LICSW and Margaret M. Hayes
Berit Pratt and Cornelia Smith
Charles Q. A. Pratt and Alexandra I. England
Brian Price, MD and Paul D. Anagnostos
Carla Procaskey and D. Anthony Flanders
Michael Prokosch and Rebecca A. Pierce
Philip E. Pryor
Judith M. Quanrud and Richard B. Quanrud
Maureen Quinn-Dupont
Maria A. Quiroga and Alvin Shiggs
Joseph D. Raccuglia, Jr.
Cara Rader
Alicia and William Ramos
Brian Ramos
Dante A. Ramos and Ryan Smith
Dennis R. Ramsier
Jeffrey T. Ranahan
Raushi and Sylvia Raushi
Robert and Wendy Reasenberg
Abram Recht and Martha Recht
Charlotte E. Reece
Mark W. Register
Sheila B. Rehrig and Brian H. Rehrig
Rachel D. Reisman
Michael L. Reney and Alexander Cruz
Ken Reyes and David M. Slatcher
Phyllis D. Ribakoff
Gena Ricciardi
Louise B. Rice and Tess Ewing
Bruce Ricker and Karolyn Ricker
Louis F. Risoli and Charles B. Fisk
Peter E. Rivard
Janet P. Robbins
John G. Robinson and Ragnhild Fredriksen
Carol A. Roby and Michele Rubin
Jose L. Romero, Jr. and William I. Allison
Valentina Rosa
Jon Z. Rosbrook
Paul and Carol Rose
Abby S. Rosenberg
Leon V. Rosenberg and Marilyn L. Rosenberg
Michael Rosenfeld and Naomi Rosenfeld
Jay K. Rosengard
Jonathan S. Rotenberg
Karen S. Rotenberg and Michael Rotenberg
Ethel R. Roumeliotis
L. Mari Rovang and Howard L. Mathison
Arlene Rubin
David J. Russo, Jr.
John P. Ryan
Michael P. Ryan
Elizabeth A. Saef and Edward C. Saef
Steve A. Safren, PhD and William F. Pirl, MD
Arnold E. Sapenter and Joseph C. Reed, PhD
James C. Sargent
Mary Kate Savini
John Scanlon
John N. Schaechter
John J. Schaeck
Stephen E. Schlesinger
Carole Schlessinger
James W. Schmidt and Jane E. MacDonald
Jon P. Schum and Ronald V. Lacro
Warren M. Schur
Anthony Schwartz and Claudia Schwartz
Susan G. Schwarz and Philip S. Schwarz
Carl M. Sciortino, Jr., MPA and Francis P. Brown
Mary L. Scudder
Lisa E. Sebell-Nevins
Glenn A. Seberg
Joan M. Seifert
Robert W. Seifert
Ellen Semonoff
Carol A. Sestito and Kathleen A. Bower
Douglas P. Shaheen and James Rodenmacher
Lyn Shamban
Brian S. Shannon and Keith Bell
Stacie M. Shapiro and Alan I. Shapiro
Sarah A. Sharpe
William S. Shaw, PhD, PE and Paul Silva
Gregory J. Shesko and Marilyn M. Shesko
Donald L. Shulman and Jill D. Shulman
Diane Sidorowicz and Lourdes Rodriguez
Christine W. Siegrist and Richard Siegrist
Andrew Sigel
Tony Sigel
James K. Sisterson and Ellen S. Kemp
Michael Skrip and James M. Brown
Luther W. Smith
Pamela A. Smith and Steven E. Thomas
Willard A. Smith and Regina M. Scanlan
Gregory Snow
Richard L. Snow
Kevin O’Laughlin and Gregg Snyder
Diane L. Sokal and Randolph Meiklejohn
Frank T. Solensky
Judith W. Solsken
Susan Sommer
Virginia L. Spaulding
Douglas Spencer
Janet Spencer
James Spriggs
Tige T. Stading and Brian Younger
Sally A. Stalker
Blaze A. Stancampiano
Daniel and Susan Stec
Charles Steenburg
Caleb Paul Stewart
Lise Striar and Myles Striar
Claire M. Sullivan
Jo M. Sullivan and Peter Boyd
Christopher Sutherland and Steve Quezada
Deb G. Taft and Terri L. Rutter
Joseph Takarewski and Craig Sato
Amy J. Tananbaum
Timothy J. Tardiff and Annalee Tardiff
Fred A. Taub and Susan C. Cohen
Fred M. Taylor
Patricia A. Tecu and William F. Tecu
Peter Tenggren and Warren Mitchell
Hal Tepfer and Stacie L. Simon
Vic Terawskyj
Teresa Shidong Hu Memorial Fund
Joseph P. Texeira and Patricia Texeira
Carol G. Thomas
Diane Thomas
Ulysses E. Thomas
John W. Titus
Mark E. Toney and Daniel J. Hartigan
Paul and Kirsten Toomey
Laurence M. Traiman
Mark A. Tries
Steven J. Tromp
Kathleen A. Tucker
Leigh J. Tucker and Stephen R. Mehrtens
Robert F. Tucker
Patricia Turner
Jonathan M. Urbach
Kenneth A. Vaidulas
Dorothy A. Van Ryzin
Joseph C. Veneto
Robin F. Verdier
Mark Vogel
Richard Voos
Ellen Wade, Esq. and Maureen Brodoff, Esq.
James C. Wadleigh
Cathy L. Walker
J. Scott Walker
Wanda Wallace
Judith H. Walsh and Robert T. Walsh
Spencer D. Warncke and Theresa A. Belmonte
Donald R. Warren
Senator Elizabeth Warren and Bruce H. Mann, PhD
Kendall P. Watts and Robert T. Derry
Linda C. Watts
Thompson Webb and Joan M. Webb
Irene M. Weigel and Lynn B. Weigel
Robert S. Weinstein and Elizabeth S. Ginsburg
Angelika Weis-Amon
Susan K. Weiss
Lynn G. Weissberg
Karen A. Welling
Mary K. Werler
P.J. Wheeler
Anne M. White
Philip White
Christine E. Whiteside
Ann M. S. Wiencek and Paul R. Wiencek
Louis Wiley
Kim Williams and Trevor Miller
William H. Williams and Sally H. M. Williams
Robert Willis
Jean and Richard Wilson
Rosemary N. Winfield
Henry N. Winslow
John F. Winterle, DMD
Steven J. Wolf
John P. Wolfarth and Kevin W. Powers
Michael T. Wong, MD
Christopher A. Wood
Rufus Woodard and Oliver Pomeroy, MD
Donald E. Woodford
Adam A. Wright and Joseph J. Noonan
R. S. Wright
Kevin P. Wulff
Donald M. Wunder and James A. Oliver
Kathy and Richard Wunderlich
Marc Wurbel and Jerome Urvoy
David Wypij and Timothy M. Baum
Joblin C. Younger, Esq.
Diana Yount
Richard J. Yurko
Albert P. Zabin and Judith L. Zabin
Leora R. Zeitlin and Stuart S. Kelter
Joseph D. Zibrak, MD
Stephen H. Zinner, MD
Michael F. Zito
Robert Zverina and Kathy A. Spiegelman
Anonymous (3)
Godwin C. Aduba and Tim Byrne
Bailey Andrews
Mary Ellen M. Andrews
Clint Attebery
Anita Baglaneas
Ashley Banfield and Emily Drahzal
Erin Bates-McNamara
Patricia Baudoin and Madge Kaplan
Davia Berlfein
John-Paul Bettencourt, DO, MPH
Mitchell Bilczewski
Andrew E. Bishop
Richard Blank and Lauren Inker
Mara Blesoff
Shelley R. Bochner and Richard W. Boylan
Marcus C. Bogue III and Nancy A. Bogue
Kyle D. Bowman and Patrick Dykes
Graham T. Brown
Amy Burke
Michael C. Burns
Kathleen Cammarota
Sean Camp
Alexander G. Carlock
Francisco Castro and Richard D. McCarthy
Stewart and Patricia Chapin
Gary A. Christensen
Jacqueline Chu
Terry Clewley
Bren M. Cole
Gillian Comito
Brianna Connolly
Patricia A. Connolly, MD
Richard T. Conway
Matthew R. Cotty
Rebecca Davis-Carden and Chloe Davis-Carden
Edward P. Divino
Katelyn Dolan, PT, DPT
Alma-Lynn Dupont
Donna and Gerry Dyer
Michael Erb
Gary Fallas
Janice Forsstrom
Andrew Foster
Thomas E. Francione
Alexander Freedman
Janet and Andrew Gainer-Dewar
Isabella M. Gambill
Elsa Gelin
David A. Georgantas
Marc Giles and Andrea Maher
Sharon Glasser
Alexa A. Gomez
Alfredo Gomez
Cynthia M. Goncalves and Shane A. Depina
Eric C. Green
Darrel Griffin
Anthony Grillo
Megan Hall and Honor MacNaughton
Mitchell Hamilton
Taylor S. Harris
Timothy B. Harwood
Kristie Helms
John S. Hoag
Mary Ellen and Paul Hoberg
Andy Huang
Christopher Iaquinto and Sara Mattern
Eric R. Jaukkuri
Lorraine Jones and Elizabeth Halstead
Steven L. Jones and David Langer
Judy Kaplan
William S. Kaufman
Kenneth W. Kendrick, Jr.
Audrea Laffely and Sarah Madey
Cei Lambert
Mary Landrigan-Ossar, MD, PhD and Jacob Ossar
Nicole Langlois
Susan LaRosa
Ted T. Lee
Nadya Lefaivre
Joanne G. Lembo and Lee Williams
Brian P. Levin
Dana Lyford
Maureen A. Maimone and Carmine Maimone
Mina S. Makarious
Elizabeth and Lisa Marchetti
Stephen Martyak
Robert McBride
Craig McClain, MD, MPH and Natalie McClain
Sarah McWhirter
Michael Meidinger
Roland Merchant
Matthew Metivier
Paul O. Miller
Renee L. Miltz
Neal Minahan and Eric Archibald
Katharine Moore
Kendra E. Moore, PhD
Richard S. Morgan and Charles E. Smith
Bess Moser
Alex Myers and Lisa Tipp
The Naida S. Wharton Foundation
Gregory B. Nash
John Nay
Mustafa Noor, MD, FACP and Gordon Nebeker
Michael Oliveri
Richard Osgood
Jon Pate
Pelz Charitable Lead Trust
Marcia Pence and F. Howard Pence, Jr.
Wendy Perez
Corbin Petro and Jessica Gelman
Elizabeth Pilgrim
Trevor Pollack
David J. Poorvu and Nancy Poorvu
Adrianna Preston-Sicari and Amanda Preston-Sicari
Ernest J. Pusateri
Jeanette Quinlan
Helen Raizen and Kathy MacDonald
Rebecca P. Rehm
Lucille Rexroad
Amy Ross and Dana M. Ross
Lynda Rubin
YK Lee Rubin
Jonathan M. Ruiz
Phil Saines
Vardit Samuels and Richard Samuels
Stephanie Sandler
Fillip Saraiva
Paul Sherman and Susan Gill
Douglas B. Skillins and Karen A. Skillins
Leslie Smith
Naomi Sobel and Becky Silverstein
Daniel Solworth
Erina and Julia Spiegelman
Joseph Sullivan III and Jay Qu
Jeffrey Sulloway
Dominick Tribone
Diane M. Tucker
Charles Turgeon
Patricia Umile
Steven J. Vacca
John F. Wardle
John C. Welch, DNP
Todd Williams
Scott R. Wilson
Sara Winthrop
James Witek and Mark D. Pettegrow
Lauren E. Wojtkun
George D. Wright IV
Brady Wyrtzen
John Yazbek
Katelyn Yorra
Carolyn R. Young
Yijie Zhang, PhD
Jose R. Zorola
Anonymous (3)
Casey Accardi
Matthew Angelosanto
Steven Auerbach and Mark Scofield
Jiray G. Avedisian
Ayla Axeloons
Nicholas Beach
Alyssa Beauchamp
Jimmy Biblarz
Heidi Boucher
Jean-Phillip Brignol
Carly Broadwell
William B. Brockman and Lucy E. Hadden
Jack Bruno
Soltan A. Bryce
Dr. K. Mahala Burn
Carson Burrington
Jessica T. Caponigro
Richard B. Carey
Kevin Cassidy and Lindsay Hurley
Mary P. Chatfield
Chris Chrisanthopulos
Bruce Clark
Tim Coakley and Angela Menard
T. Coletti
Erina Colombo
Michael Condon
Stephanie Connell
Ross Cooper
Roger Cyr and William Gasdaska
David J. Davis and Tracy Thompson
Nicholas Dials and Dustin Henderson
Claire Douglas
Nicki and Elizabeth Eastburn
Chad A. Elgeziry
Jessica Fairbanks
Theresa H. Ferran and Arianna Mitropoulos
Andrew Ferris
Judy G. Gale
Phillip Giacomoni
Louesa M. Gillespie
Kevin Govoni
Warren Green
Aaron Halleck
Matthew Hamilton
Jan Hanson
Katherine Heckman
Christina Heinrich
Clinton A. Heitman
Helen C. and Michael C. Horn
Ryan C. Jarvis
Cameron Judkins and Joshua C. Judkins, PhD
Cornelia A. Kammerer
Emily Kang
Mitchell Katz
Jake Kenney
Christine Koh
William G. LaBonte and Ruthie LaBonte
Matthew D. LaBrie
Luke Lennon
Richard Lerner
Brandy Lilly
Alisa Lincoln, MPH, PhD
Ryan MacLean
Shelby Magliari
Sofia Mankin
Hanna Mar
Will Martin
Matt Mattozzi
Zachary D. McCabe
Stephen D. McCreary and Sandra McCreary
Matthew McGuirk
Malinda J. McPherson
Jaelyn Montes
George J. Mullen
Ken Nimblett
Patricia Noone
Christine Ott
Heather Ouellette
Pierre J. Peloquin and Michele C. Peloquin
Natercia Pereira
Jennifer and Catherine Petter
Monika Pichler
Brian Powrie and Adam Krueger
Jeffrey Race
Emmett Reuder
Donald J. Richgels and Mary Richgels
Joey Riddle
Caitlin Riley
Alessandra R. Robinson
Daniel Rodas
Shawon Rodger
Dalton Rodriguez
Richard Rubinstein
Earle and Pamela Rugg
Brian Sandstrom
Tyler Sanslow, DMD
Dorothy A. Savarese
William J. Sawyer and Pamela P. Sawyer
George Scialabba
Rachel Sebellshavit
Julian Serrao
Jeremy Shaffer
Michael A. Spataro
Michael Sullivan
Jona Tanguay
Matthew Tenore
Brianda Thompson
Daniel Treacy
Elizabeth Tripp
Patrick Turner
Elizabeth Van Itallie
Thomas Velazquez
Alyssia Venna
Travis Waldrop and Shawn Goodwin
Lindsay Waller
Eric York Wallischeck
Brian C. Ware
Richard Waterhouse
Parker Wellington III
Fenway Health is grateful to the following individuals and companies who came forward with in-kind support, and in doing so have helped to advance Fenway’s mission.
America’s Test Kitchen
Anchorage by the Sea
Anchor’d Inc
B/SPOKE Studios
Ball Square Fine Wines
Barbershop Deluxe
Bayside Resort
Bear Moose Brewing
Bikes Not Bombs
Blu Day Spa
Book of the Month
Brattle Book Shop
Bright Lights Designs
Brix Wine Shop
Brookline Booksmith
Brown and Coconut
Caffe Nero
Cairncrest Farms
California Cryobank, Inc.
Charles River Canoe and Kayak & Paddle Boston
Club Cafe
Community Rowing, Inc.
Coolidge Yoga
Corepower Yoga – Comm Ave
Daily Burn
Down Under Yoga
Fischel
Fox City Beard
Garbage to Garden
Glo
Gunstock Mountain Resort
Haley
Hinds
Hotel Commonwealth
House of Tafari Wraps
Huntington Theatre Company
Hy-Line Cruises
Intriguing Hair
Jack Black
JP Centre Yoga
Kerr
Linda Wellness Warrior
M. Flynn Jewelry
Manduka
McInerney
Meal Mantra
Myers + Chang
New England Plastic Surgical Associates
OoOtie Boston Bow Ties
Peabody Essex Museum
Peet’s Coffee and Tea
Pilgrim Monument and Provincetown Museum
Poised Clothing
Polkadog Bakery
Provincetown Art Association and Museum
Pyara Spa & Salon
Red Dog Pet Resort & Spa Boston
Red Sox Foundation
Remnant Brewing
Saldare Body Therapy & Wellness Studio
Springfield Museums
Surfside Hotel & Suites
Swanson-Welton
The Common Man Family of Restaurants
The Elsewhere Salon
The Inn on Carleton
The Red Inn
Theatre Direct Int’l/Broadway.com
Timberland LLC
Total Image Consultants
Total Wine & More
Trill Fit
We Grow Microgreens, LLC
Gift planning is the marriage of philanthropy and sound financial planning. By making a bequest to Fenway Health through a will or trust, naming Fenway as a beneficiary of a life insurance policy or retirement plan, or creating a life income plan to support Fenway, these donors are forging a lasting legacy that benefits the people they most care for, and those who depend on Fenway.